<full-text-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/article/dtd" xmlns:bk="http://www.elsevier.com/xml/bk/dtd" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <coredata>
        <prism:url>https://api.elsevier.com/content/article/pii/S0167527317311075</prism:url>
        <dc:identifier>doi:10.1016/j.ijcard.2017.02.078</dc:identifier>
        <eid>1-s2.0-S0167527317311075</eid>
        <prism:doi>10.1016/j.ijcard.2017.02.078</prism:doi>
        <pii>S0167-5273(17)31107-5</pii>
        <dc:title>Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study </dc:title>
        <prism:publicationName>International Journal of Cardiology</prism:publicationName>
        <prism:aggregationType>Journal</prism:aggregationType>
        <pubType>fla</pubType>
        <prism:issn>01675273</prism:issn>
        <prism:volume>235</prism:volume>
        <prism:startingPage>124</prism:startingPage>
        <prism:endingPage>132</prism:endingPage>
        <prism:pageRange>124-132</prism:pageRange>
        <dc:format>text/xml</dc:format>
        <prism:coverDate>2017-05-15</prism:coverDate>
        <prism:coverDisplayDate>15 May 2017</prism:coverDisplayDate>
        <prism:copyright>© 2017 The Authors. Published by Elsevier Ireland Ltd.</prism:copyright>
        <prism:publisher>The Authors. Published by Elsevier Ireland Ltd.</prism:publisher>
        <dc:creator>van Boven, Nick</dc:creator>
        <dc:creator>Akkerhuis, K. Martijn</dc:creator>
        <dc:creator>Anroedh, Sharda S.</dc:creator>
        <dc:creator>Rizopoulos, Dimitris</dc:creator>
        <dc:creator>Pinto, Yigal</dc:creator>
        <dc:creator>Battes, Linda C.</dc:creator>
        <dc:creator>Hillege, Hans L.</dc:creator>
        <dc:creator>Caliskan, Kadir C.</dc:creator>
        <dc:creator>Germans, Tjeerd</dc:creator>
        <dc:creator>Manintveld, Olivier C.</dc:creator>
        <dc:creator>Cornel, Jan-Hein</dc:creator>
        <dc:creator>Constantinescu, Alina A.</dc:creator>
        <dc:creator>Boersma, Eric</dc:creator>
        <dc:creator>Umans, Victor A.</dc:creator>
        <dc:creator>Kardys, Isabella</dc:creator>
        <dc:description>
                  Background
                  Several studies have suggested circulating microRNAs (miRs) are associated with heart failure, but these studies were small, and limited to single miR measurements.
                  We examined 7 miRs which were previously linked to heart failure, and tested whether their temporal expression level predicts prognosis in a prospective cohort of chronic heart failure (CHF) patients.

                  Methods and results
                  In 2011–2013, 263 CHF patients were included. At inclusion and subsequently every 3months, we measured 7miRs. The primary endpoint (PE) comprised heart failure hospitalization, cardiovascular mortality, cardiac transplantation and LVAD implantation. Associations between temporal miR patterns and the PE were investigated by joint modelling, which combines mixed models with Cox regression.
                  Mean age was 67±13years, 72% were men and 27% NYHA classes III–IV. We obtained 873 blood samples (median 3 [IQR 2–5] per patient). The PE was reached in 41 patients (16%) during a median follow-up of 0.9 [0.6–1.4] years. The temporal pattern of miR-22-3p was independently associated with the PE (HR [95% CI] per doubling of level: 0.64 [0.47–0.77]). The instantaneous change in level (slope of the temporal miR pattern) of miR-22-3p was also independently associated with the PE (HR [95% CI] per doubling of slope: 0.33 [0.20–0.51]). These associations remained statistically significant after adjustment for temporal patterns of NT-proBNP, Troponin T and CRP.

                  Conclusions
                  The temporal pattern of circulating miR-22-3p contains important prognostic and independent information in CHF patients. This concept warrants further investigation in larger series with extended follow-up.
        </dc:description>
        <openaccess>1</openaccess>
        <openaccessArticle>true</openaccessArticle>
        <openaccessType>Full</openaccessType>
        <openArchiveArticle>false</openArchiveArticle>
        <openaccessSponsorName>VSNU</openaccessSponsorName>
        <openaccessSponsorType>FundingBody</openaccessSponsorType>
        <openaccessUserLicense>http://creativecommons.org/licenses/by/4.0/</openaccessUserLicense>
        <dcterms:subject>MicroRNAs</dcterms:subject>
        <dcterms:subject>Biomarkers</dcterms:subject>
        <dcterms:subject>Chronic heart failure</dcterms:subject>
        <dcterms:subject>Prognostication</dcterms:subject>
        <dcterms:subject>Mortality</dcterms:subject>
        <link href="https://api.elsevier.com/content/article/pii/S0167527317311075" rel="self"/>
        <link href="https://www.sciencedirect.com/science/article/pii/S0167527317311075" rel="scidir"/>
    </coredata>
    <objects>
        <object ref="gr1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="181" height="164" size="15297">https://api.elsevier.com/content/object/eid/1-s2.0-S0167527317311075-gr1.sml?httpAccept=%2A%2F%2A</object>
        <object ref="gr2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="135" size="16484">https://api.elsevier.com/content/object/eid/1-s2.0-S0167527317311075-gr2.sml?httpAccept=%2A%2F%2A</object>
        <object ref="gr3" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="76" size="6403">https://api.elsevier.com/content/object/eid/1-s2.0-S0167527317311075-gr3.sml?httpAccept=%2A%2F%2A</object>
        <object ref="gr1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="625" height="566" size="88866">https://api.elsevier.com/content/object/eid/1-s2.0-S0167527317311075-gr1.jpg?httpAccept=%2A%2F%2A</object>
        <object ref="gr2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="335" height="207" size="30718">https://api.elsevier.com/content/object/eid/1-s2.0-S0167527317311075-gr2.jpg?httpAccept=%2A%2F%2A</object>
        <object ref="gr3" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="1069" height="373" size="52619">https://api.elsevier.com/content/object/eid/1-s2.0-S0167527317311075-gr3.jpg?httpAccept=%2A%2F%2A</object>
        <object ref="gr1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1660" height="1504" size="309448">https://api.elsevier.com/content/object/eid/1-s2.0-S0167527317311075-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object>
        <object ref="gr2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1486" height="919" size="174302">https://api.elsevier.com/content/object/eid/1-s2.0-S0167527317311075-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object>
        <object ref="gr3" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="4734" height="1651" size="497681">https://api.elsevier.com/content/object/eid/1-s2.0-S0167527317311075-gr3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="mmc1" category="standard" type="APPLICATION" multimediatype="Microsoft Word file" mimetype="application/word" size="72192">https://api.elsevier.com/content/object/eid/1-s2.0-S0167527317311075-mmc1.doc?httpAccept=%2A%2F%2A</object>
    </objects>
    <scopus-id>85014215458</scopus-id>
    <scopus-eid>2-s2.0-85014215458</scopus-eid>
    <pubmed-id>28274577</pubmed-id>
    <link href="https://api.elsevier.com/content/abstract/scopus_id/85014215458" rel="abstract"/>
    <originalText>
        <xocs:doc xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd">
            <xocs:meta xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <xocs:content-family>serial</xocs:content-family>
      <xocs:content-type>JL</xocs:content-type>
      <xocs:cid>271057</xocs:cid>
      <xocs:ssids>
         <xocs:ssid type="alllist">291210</xocs:ssid>
         <xocs:ssid type="subj">291896</xocs:ssid>
         <xocs:ssid type="subj">291900</xocs:ssid>
         <xocs:ssid type="content">31</xocs:ssid>
         <xocs:ssid type="oa">90</xocs:ssid>
      </xocs:ssids>
      <xocs:srctitle>International Journal of Cardiology</xocs:srctitle>
      <xocs:normalized-srctitle>INTERNATIONALJOURNALCARDIOLOGY</xocs:normalized-srctitle>
      <xocs:orig-load-date yyyymmdd="20170222">2017-02-22</xocs:orig-load-date>
      <xocs:available-online-date yyyymmdd="20170222">2017-02-22</xocs:available-online-date>
      <xocs:vor-load-date yyyymmdd="20170322">2017-03-22</xocs:vor-load-date>
      <xocs:vor-available-online-date yyyymmdd="20170322">2017-03-22</xocs:vor-available-online-date>
      <xocs:ew-transaction-id>2017-03-22T19:50:36</xocs:ew-transaction-id>
      <xocs:eid>1-s2.0-S0167527317311075</xocs:eid>
      <xocs:pii-formatted>S0167-5273(17)31107-5</xocs:pii-formatted>
      <xocs:pii-unformatted>S0167527317311075</xocs:pii-unformatted>
      <xocs:doi>10.1016/j.ijcard.2017.02.078</xocs:doi>
      <xocs:item-stage>S300</xocs:item-stage>
      <xocs:item-version-number>S300.1</xocs:item-version-number>
      <xocs:item-weight>FULL-TEXT</xocs:item-weight>
      <xocs:hub-eid>1-s2.0-S0167527317X00065</xocs:hub-eid>
      <xocs:timestamp yyyymmdd="20170322">2017-03-22T21:11:06.209699-04:00</xocs:timestamp>
      <xocs:dco>0</xocs:dco>
      <xocs:tomb>0</xocs:tomb>
      <xocs:date-search-begin>20170515</xocs:date-search-begin>
      <xocs:year-nav>2017</xocs:year-nav>
      <xocs:indexeddate epoch="1487786001">2017-02-22T17:53:21.709486Z</xocs:indexeddate>
      <xocs:articleinfo>articleinfo articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid fundingbodyid hubeid indexeddate issn issnnorm itemstage itemtransactionid itemweight oauserlicense openaccess openarchive pg pgfirst pglast pii piinorm pubdatestart pubdatetxt pubyr sectiontitle sortorder sponsoredaccesstype srctitle srctitlenorm srctype ssids alllist content oa subj subheadings suppl tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure table e-component body acknowledge affil articletitle auth authfirstini authfull authkeywords authlast grantsponsor orcid primabst ref</xocs:articleinfo>
      <xocs:issns>
         <xocs:issn-primary-formatted>0167-5273</xocs:issn-primary-formatted>
         <xocs:issn-primary-unformatted>01675273</xocs:issn-primary-unformatted>
      </xocs:issns>
      <xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type>
      <xocs:funding-body-id>VSNUGOLD</xocs:funding-body-id>
      <xocs:crossmark is-crossmark="1">true</xocs:crossmark>
      <xocs:vol-first>235</xocs:vol-first>
      <xocs:volume-list>
         <xocs:volume>235</xocs:volume>
      </xocs:volume-list>
      <xocs:suppl>C</xocs:suppl>
      <xocs:vol-iss-suppl-text>Volume 235</xocs:vol-iss-suppl-text>
      <xocs:sort-order>21</xocs:sort-order>
      <xocs:first-fp>124</xocs:first-fp>
      <xocs:last-lp>132</xocs:last-lp>
      <xocs:pages>
         <xocs:first-page>124</xocs:first-page>
         <xocs:last-page>132</xocs:last-page>
      </xocs:pages>
      <xocs:cover-date-orig>
         <xocs:start-date>20170515</xocs:start-date>
      </xocs:cover-date-orig>
      <xocs:cover-date-text>15 May 2017</xocs:cover-date-text>
      <xocs:cover-date-start>2017-05-15</xocs:cover-date-start>
      <xocs:cover-date-year>2017</xocs:cover-date-year>
      <xocs:hub-sec>
         <xocs:hub-sec-title>Orginal Articles</xocs:hub-sec-title>
      </xocs:hub-sec>
      <xocs:document-type>article</xocs:document-type>
      <xocs:document-subtype>fla</xocs:document-subtype>
      <xocs:copyright-line>© 2017 The Authors. Published by Elsevier Ireland Ltd.</xocs:copyright-line>
      <xocs:normalized-article-title>SERIALLYMEASUREDCIRCULATINGMIR223PABIOMARKERFORADVERSECLINICALOUTCOMEINPATIENTSCHRONICHEARTFAILUREBIOSHIFTSTUDY</xocs:normalized-article-title>
      <xocs:normalized-first-auth-surname>VANBOVEN</xocs:normalized-first-auth-surname>
      <xocs:normalized-first-auth-initial>N</xocs:normalized-first-auth-initial>
      <xocs:item-toc>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>1</xocs:item-toc-label>
            <xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>2</xocs:item-toc-label>
            <xocs:item-toc-section-title>Methods</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Patients</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Baseline assessment</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Follow-up visits</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>Blood sampling and miR measurement</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.5</xocs:item-toc-label>
               <xocs:item-toc-section-title>Clinical study endpoints</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.6</xocs:item-toc-label>
               <xocs:item-toc-section-title>Statistical analysis</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>3</xocs:item-toc-label>
            <xocs:item-toc-section-title>Result</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Baseline characteristics</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Clinical endpoints</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Temporal miR patterns and the primary endpoint</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>Slope and area under the curve of the temporal miR patterns and the primary endpoint</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.5</xocs:item-toc-label>
               <xocs:item-toc-section-title>Temporal patterns of miRs, NT-proBNP, Hs-TNT and CRP combined in a multiple-marker model</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.6</xocs:item-toc-label>
               <xocs:item-toc-section-title>Repeated miR measurements and other biomarkers</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>4</xocs:item-toc-label>
            <xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-section-title>Funding sources</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-section-title>Conflicts of interest</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:acknowledgment">
            <xocs:item-toc-section-title>Acknowledgements</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:bibliography">
            <xocs:item-toc-section-title>References</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
      </xocs:item-toc>
      <xocs:references>
         <xocs:ref-info refid="rf0005">
            <xocs:ref-normalized-surname>PONIKOWSKI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>891</xocs:ref-first-fp>
            <xocs:ref-last-lp>975</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0010">
            <xocs:ref-normalized-surname>YANCY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>e147</xocs:ref-first-fp>
            <xocs:ref-last-lp>e239</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0015">
            <xocs:ref-normalized-surname>JANUZZI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>500</xocs:ref-first-fp>
            <xocs:ref-last-lp>507</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0020">
            <xocs:ref-normalized-surname>DECOUTO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>334</xocs:ref-first-fp>
            <xocs:ref-last-lp>344</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0025">
            <xocs:ref-normalized-surname>SAVARESE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-article-number>e58287</xocs:ref-article-number>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0030">
            <xocs:ref-normalized-surname>PORAPAKKHAM</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>507</xocs:ref-first-fp>
            <xocs:ref-last-lp>514</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0035">
            <xocs:ref-normalized-surname>MILLER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2007</xocs:ref-pub-year>
            <xocs:ref-first-fp>249</xocs:ref-first-fp>
            <xocs:ref-last-lp>257</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0040">
            <xocs:ref-normalized-surname>YAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2005</xocs:ref-pub-year>
            <xocs:ref-first-fp>698</xocs:ref-first-fp>
            <xocs:ref-last-lp>704</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0045">
            <xocs:ref-normalized-surname>TROUGHTON</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>16</xocs:ref-first-fp>
            <xocs:ref-last-lp>24</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0050">
            <xocs:ref-normalized-surname>BARTEL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>281</xocs:ref-first-fp>
            <xocs:ref-last-lp>297</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0055">
            <xocs:ref-normalized-surname>GILAD</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-article-number>e3148</xocs:ref-article-number>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0060">
            <xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>2111</xocs:ref-first-fp>
            <xocs:ref-last-lp>2116</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0065">
            <xocs:ref-normalized-surname>COSTAMARTINS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>1567</xocs:ref-first-fp>
            <xocs:ref-last-lp>1576</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0070">
            <xocs:ref-normalized-surname>CREEMERS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>483</xocs:ref-first-fp>
            <xocs:ref-last-lp>495</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0075">
            <xocs:ref-normalized-surname>VOGEL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>410</xocs:ref-first-fp>
            <xocs:ref-last-lp>418</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0080">
            <xocs:ref-normalized-surname>ZAMPETAKI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>290</xocs:ref-first-fp>
            <xocs:ref-last-lp>299</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0085">
            <xocs:ref-normalized-surname>CORSTEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>499</xocs:ref-first-fp>
            <xocs:ref-last-lp>506</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0090">
            <xocs:ref-normalized-surname>OLIVIERI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>531</xocs:ref-first-fp>
            <xocs:ref-last-lp>536</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0095">
            <xocs:ref-normalized-surname>GOLDRAICH</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>135</xocs:ref-first-fp>
            <xocs:ref-last-lp>141</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0100">
            <xocs:ref-normalized-surname>BAUTERS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>1837</xocs:ref-first-fp>
            <xocs:ref-last-lp>1840</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0105">
            <xocs:ref-normalized-surname>TIJSEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>1035</xocs:ref-first-fp>
            <xocs:ref-last-lp>1039</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0110">
            <xocs:ref-normalized-surname>DICKINSON</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>650</xocs:ref-first-fp>
            <xocs:ref-last-lp>659</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0115">
            <xocs:ref-normalized-surname>NAGAPRASAD</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>27487</xocs:ref-first-fp>
            <xocs:ref-last-lp>27499</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0120">
            <xocs:ref-normalized-surname>GOREN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>147</xocs:ref-first-fp>
            <xocs:ref-last-lp>154</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0125">
            <xocs:ref-normalized-surname>MCMURRAY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>1787</xocs:ref-first-fp>
            <xocs:ref-last-lp>1847</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0130">
            <xocs:ref-normalized-surname>DICKSTEIN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>2388</xocs:ref-first-fp>
            <xocs:ref-last-lp>2442</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0135">
            <xocs:ref-normalized-surname>PAULUS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2007</xocs:ref-pub-year>
            <xocs:ref-first-fp>2539</xocs:ref-first-fp>
            <xocs:ref-last-lp>2550</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0140">
            <xocs:ref-normalized-surname>RAO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>585</xocs:ref-first-fp>
            <xocs:ref-last-lp>594</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0145">
            <xocs:ref-normalized-surname>RIZOPOULOS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>1</xocs:ref-first-fp>
            <xocs:ref-last-lp>33</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0150">
            <xocs:ref-normalized-surname>RIZOPOULOS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>JOINTMODELSFORLONGITUDINALTIMETOEVENTDATAAPPLICATIONSINR</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0155">
            <xocs:ref-normalized-surname>LI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>543</xocs:ref-first-fp>
            <xocs:ref-last-lp>548</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0160">
            <xocs:ref-normalized-surname>HUANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>267</xocs:ref-first-fp>
            <xocs:ref-last-lp>272</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0165">
            <xocs:ref-normalized-surname>HUANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>1234</xocs:ref-first-fp>
            <xocs:ref-last-lp>1243</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0170">
            <xocs:ref-normalized-surname>GURHA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>2751</xocs:ref-first-fp>
            <xocs:ref-last-lp>2761</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0175">
            <xocs:ref-normalized-surname>GUPTA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>1557</xocs:ref-first-fp>
            <xocs:ref-last-lp>1571</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0180">
            <xocs:ref-normalized-surname>KNEZEVIC</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>12913</xocs:ref-first-fp>
            <xocs:ref-last-lp>12926</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>I</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0185">
            <xocs:ref-normalized-surname>NAGALINGAM</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>11216</xocs:ref-first-fp>
            <xocs:ref-last-lp>11232</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0190">
            <xocs:ref-normalized-surname>NAGALINGAM</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>27199</xocs:ref-first-fp>
            <xocs:ref-last-lp>27214</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0195">
            <xocs:ref-normalized-surname>GANESAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>2097</xocs:ref-first-fp>
            <xocs:ref-last-lp>2106</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0200">
            <xocs:ref-normalized-surname>FANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>410</xocs:ref-first-fp>
            <xocs:ref-last-lp>423</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0205">
            <xocs:ref-normalized-surname>LI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>5267</xocs:ref-first-fp>
            <xocs:ref-last-lp>5275</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>X</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0210">
            <xocs:ref-normalized-surname>SMALL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>4218</xocs:ref-first-fp>
            <xocs:ref-last-lp>4223</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0215">
            <xocs:ref-normalized-surname>BESLER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0220">
            <xocs:ref-normalized-surname>VEGTER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>457</xocs:ref-first-fp>
            <xocs:ref-last-lp>468</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>
         </xocs:ref-info>
      </xocs:references>
      <xocs:refkeys>
         <xocs:refkey3>VANBOVENX2017X124</xocs:refkey3>
         <xocs:refkey4lp>VANBOVENX2017X124X132</xocs:refkey4lp>
         <xocs:refkey4ai>VANBOVENX2017X124XN</xocs:refkey4ai>
         <xocs:refkey5>VANBOVENX2017X124X132XN</xocs:refkey5>
      </xocs:refkeys>
      <xocs:open-access>
         <xocs:oa-article-status is-open-access="1" is-open-archive="0">Full</xocs:oa-article-status>
         <xocs:oa-access-effective-date>2017-02-23T16:49:18Z</xocs:oa-access-effective-date>
         <xocs:oa-sponsor>
            <xocs:oa-sponsor-type>FundingBody</xocs:oa-sponsor-type>
            <xocs:oa-sponsor-name>VSNU</xocs:oa-sponsor-name>
         </xocs:oa-sponsor>
         <xocs:oa-user-license>http://creativecommons.org/licenses/by/4.0/</xocs:oa-user-license>
      </xocs:open-access>
      <xocs:self-archiving>
         <xocs:sa-start-date>2018-03-22T00:00:00.000Z</xocs:sa-start-date>
         <xocs:sa-embargo-status>UnderEmbargo</xocs:sa-embargo-status>
         <xocs:sa-user-license>http://creativecommons.org/licenses/by-nc-nd/4.0/</xocs:sa-user-license>
      </xocs:self-archiving>
      <xocs:copyright-info>
         <xocs:cp-license-lines>
            <xocs:cp-license-line lang="en">This is an open access article under the CC BY license.</xocs:cp-license-line>
         </xocs:cp-license-lines>
         <xocs:cp-notices>
            <xocs:cp-notice lang="en">© 2017 The Authors. Published by Elsevier Ireland Ltd.</xocs:cp-notice>
         </xocs:cp-notices>
      </xocs:copyright-info>
      <xocs:attachment-metadata-doc>
         <xocs:attachment-set-type>item</xocs:attachment-set-type>
         <xocs:pii-formatted>S0167-5273(17)31107-5</xocs:pii-formatted>
         <xocs:pii-unformatted>S0167527317311075</xocs:pii-unformatted>
         <xocs:eid>1-s2.0-S0167527317311075</xocs:eid>
         <xocs:doi>10.1016/j.ijcard.2017.02.078</xocs:doi>
         <xocs:cid>271057</xocs:cid>
         <xocs:timestamp>2017-03-22T15:56:08.934608-04:00</xocs:timestamp>
         <xocs:cover-date-start>2017-05-15</xocs:cover-date-start>
         <xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type>
         <xocs:funding-body-id>VSNUGOLD</xocs:funding-body-id>
         <xocs:attachments>
            <xocs:web-pdf>
               <xocs:attachment-eid>1-s2.0-S0167527317311075-main.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0167527317311075/MAIN/application/pdf/853882e716e989980df4b0c990696662/main.pdf</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0167527317311075/MAIN/application/pdf/853882e716e989980df4b0c990696662/main.pdf</xocs:ucs-locator>
               <xocs:filename>main.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>true</xocs:pdf-optimized>
               <xocs:filesize>661455</xocs:filesize>
               <xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose>
               <xocs:web-pdf-page-count>9</xocs:web-pdf-page-count>
               <xocs:web-pdf-images>
                  <xocs:web-pdf-image>
                     <xocs:attachment-eid>1-s2.0-S0167527317311075-main_1.png</xocs:attachment-eid>
                     <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0167527317311075/PREVIEW/image/png/f2d8e62a7ab53d8269d54420bb6c2bc9/main_1.png</xocs:ucs-locator>
                     <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0167527317311075/PREVIEW/image/png/f2d8e62a7ab53d8269d54420bb6c2bc9/main_1.png</xocs:ucs-locator>
                     <xocs:filename>main_1.png</xocs:filename>
                     <xocs:extension>png</xocs:extension>
                     <xocs:filesize>59085</xocs:filesize>
                     <xocs:pixel-height>849</xocs:pixel-height>
                     <xocs:pixel-width>656</xocs:pixel-width>
                     <xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type>
                     <xocs:pdf-page-num>1</xocs:pdf-page-num>
                  </xocs:web-pdf-image>
               </xocs:web-pdf-images>
            </xocs:web-pdf>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0167527317311075-gr1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0167527317311075/gr1/THUMBNAIL/image/gif/d5d6c1e3ced2b63c5e53a33bc735f43e/gr1.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0167527317311075/gr1/THUMBNAIL/image/gif/d5d6c1e3ced2b63c5e53a33bc735f43e/gr1.sml</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>15297</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>181</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0167527317311075-gr2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0167527317311075/gr2/THUMBNAIL/image/gif/5da9128a2e0a822f56160ae8632b173e/gr2.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0167527317311075/gr2/THUMBNAIL/image/gif/5da9128a2e0a822f56160ae8632b173e/gr2.sml</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>16484</xocs:filesize>
               <xocs:pixel-height>135</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0167527317311075-gr3.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0167527317311075/gr3/THUMBNAIL/image/gif/04ccf74f922f2d47740b866fde933ab2/gr3.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0167527317311075/gr3/THUMBNAIL/image/gif/04ccf74f922f2d47740b866fde933ab2/gr3.sml</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>6403</xocs:filesize>
               <xocs:pixel-height>76</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0167527317311075-gr1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0167527317311075/gr1/DOWNSAMPLED/image/jpeg/bd1181f951e83c0858f7dd875683038e/gr1.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0167527317311075/gr1/DOWNSAMPLED/image/jpeg/bd1181f951e83c0858f7dd875683038e/gr1.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>88866</xocs:filesize>
               <xocs:pixel-height>566</xocs:pixel-height>
               <xocs:pixel-width>625</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0167527317311075-gr2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0167527317311075/gr2/DOWNSAMPLED/image/jpeg/1f9419c12bba6c3dbe9cd17c8c70a91e/gr2.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0167527317311075/gr2/DOWNSAMPLED/image/jpeg/1f9419c12bba6c3dbe9cd17c8c70a91e/gr2.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>30718</xocs:filesize>
               <xocs:pixel-height>207</xocs:pixel-height>
               <xocs:pixel-width>335</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0167527317311075-gr3.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0167527317311075/gr3/DOWNSAMPLED/image/jpeg/e6dbe97db71b3177c8d078f1f7eeab1d/gr3.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0167527317311075/gr3/DOWNSAMPLED/image/jpeg/e6dbe97db71b3177c8d078f1f7eeab1d/gr3.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>52619</xocs:filesize>
               <xocs:pixel-height>373</xocs:pixel-height>
               <xocs:pixel-width>1069</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0167527317311075-gr1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0167527317311075/gr1/HIGHRES/image/jpeg/7525836472ea11c5ea0a1f3936a17dd5/gr1_lrg.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0167527317311075/gr1/HIGHRES/image/jpeg/7525836472ea11c5ea0a1f3936a17dd5/gr1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>309448</xocs:filesize>
               <xocs:pixel-height>1504</xocs:pixel-height>
               <xocs:pixel-width>1660</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0167527317311075-gr2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0167527317311075/gr2/HIGHRES/image/jpeg/46fb594de7c89f897a7a1e8d1ac60dc4/gr2_lrg.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0167527317311075/gr2/HIGHRES/image/jpeg/46fb594de7c89f897a7a1e8d1ac60dc4/gr2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>174302</xocs:filesize>
               <xocs:pixel-height>919</xocs:pixel-height>
               <xocs:pixel-width>1486</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0167527317311075-gr3_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0167527317311075/gr3/HIGHRES/image/jpeg/d4747ab479e85f198d012df86488ecf8/gr3_lrg.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0167527317311075/gr3/HIGHRES/image/jpeg/d4747ab479e85f198d012df86488ecf8/gr3_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>497681</xocs:filesize>
               <xocs:pixel-height>1651</xocs:pixel-height>
               <xocs:pixel-width>4734</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0167527317311075-mmc1.doc</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0167527317311075/mmc1/MAIN/application/msword/fa1f37a4a01e8afe7c0ffa862f916858/mmc1.doc</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0167527317311075/mmc1/MAIN/application/msword/fa1f37a4a01e8afe7c0ffa862f916858/mmc1.doc</xocs:ucs-locator>
               <xocs:file-basename>mmc1</xocs:file-basename>
               <xocs:filename>mmc1.doc</xocs:filename>
               <xocs:extension>doc</xocs:extension>
               <xocs:filesize>72192</xocs:filesize>
               <xocs:attachment-type>APPLICATION</xocs:attachment-type>
            </xocs:attachment>
         </xocs:attachments>
      </xocs:attachment-metadata-doc>
   </xocs:meta>
            <xocs:serial-item xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <article xmlns="http://www.elsevier.com/xml/ja/dtd" version="5.4" docsubtype="fla" xml:lang="en">
         <item-info>
            <jid>IJCA</jid>
            <aid>24604</aid>
            <ce:pii>S0167-5273(17)31107-5</ce:pii>
            <ce:doi>10.1016/j.ijcard.2017.02.078</ce:doi>
            <ce:copyright type="other" year="2017">The Authors</ce:copyright>
         </item-info>
         <ce:floats>
            <ce:figure id="f0005">
               <ce:label>Fig. 1</ce:label>
               <ce:caption id="ca0005">
                  <ce:simple-para id="sp0005" view="all">Inclusion and exclusion criteria.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="al0005">Fig. 1</ce:alt-text>
               <ce:link id="lk0005" locator="gr1" xlink:type="simple" xlink:href="pii:S0167527317311075/gr1" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4"/>
            </ce:figure>
            <ce:figure id="f0010">
               <ce:label>Fig. 2</ce:label>
               <ce:caption id="ca0010">
                  <ce:simple-para id="sp0010" view="all">Associations between baseline MicroRNA levels and presence of ischemic cardiomyopathy.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="al0010">Fig. 2</ce:alt-text>
               <ce:link id="lk0010" locator="gr2" xlink:type="simple" xlink:href="pii:S0167527317311075/gr2" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4"/>
            </ce:figure>
            <ce:figure id="f0015">
               <ce:label>Fig. 3</ce:label>
               <ce:caption id="ca0015">
                  <ce:simple-para id="sp0015" view="all">Temporal evolution of microRNA levels. <ce:italic>Legend</ce:italic>: Temporal evolution was estimated by using mixed models. Y-axis: arbitrary units [a.u.] representing relative miRNA expression levels. X-axis: time in years as the endpoint approaches (time<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0 denotes the moment that the endpoint occurs for the patients reaching the endpoint, and the moment of right-censoring for the patients not reaching the endpoint). Red solid line: miR expression level in patients reaching the endpoint. Red dotted lines: 95% confidence interval. Black solid line: miR expression level in patients not reaching the endpoint. Black dotted line: 95% confidence interval.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="al0015">Fig. 3</ce:alt-text>
               <ce:link id="lk0015" locator="gr3" xlink:type="simple" xlink:href="pii:S0167527317311075/gr3" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4"/>
            </ce:figure>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="t0005" frame="topbot" rowsep="0" colsep="0">
               <ce:label>Table 1</ce:label>
               <ce:caption id="ca0020">
                  <ce:simple-para id="sp0020" view="all">Baseline characteristics.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="al0020">Table 1</ce:alt-text>
               <tgroup cols="2" rowsep="0" colsep="0">
                  <colspec colname="col1"/>
                  <colspec colname="col2"/>
                  <thead>
                     <row valign="top" rowsep="1">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">Total (n<hsp sp="0.25"/>=<hsp sp="0.25"/>263)</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <italic>Demographics</italic>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Age</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">67 (±<hsp sp="0.10"/>13)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Male gender</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">189 (72)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Caucasian ethnicity</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">244 (94)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <vsp sp="0.5"/>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <italic>Clinical characteristics</italic>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Body mass index kg/m<sup loc="post">2</sup>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">28 (±<hsp sp="0.10"/>5)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Heart rate, bpm</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">67 (±<hsp sp="0.10"/>12)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Systolic blood pressure, mmHg</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">122 (±<hsp sp="0.10"/>20)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Diastolic blood pressure, mmHg</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">73 (±<hsp sp="0.10"/>11)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <vsp sp="0.5"/>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <italic>Biomarker level</italic>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">NT-proBNP (pmol/L)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">139.6 (51.9 – 272.9)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">HsTNT (ng/l)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">18.0 (9.6 – 33.2)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">CRP (mg/l)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">2.2 (0.9 – 4.8)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <vsp sp="0.5"/>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <italic>Features of heart failure</italic>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Duration of heart failure, years</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">4.6 (1.7 – 9.9)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">NYHA class I</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">75 (29)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">NYHA class II</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">115 (44)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">NYHA class III or IV</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">69 (27)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Left ventricular function</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">
                           <hsp sp="1"/>Systolic dysfunction</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">250 (95)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">
                           <hsp sp="1"/>HFPEF</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">13 (5)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">LVEF<cross-ref refid="tf0005" id="cf0010">
                              <sup loc="post">a</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">32 (±<hsp sp="0.10"/>10)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <vsp sp="0.5"/>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <italic>Etiology of heart failure</italic>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Ischemic heart disease</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">117 (44)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Hypertension</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">34 (13)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Secondary to valvular heart disease</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">12 (5)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Cardiomyopathy</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">68 (26)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">
                           <hsp sp="1"/>Dilated</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">49 (19)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">
                           <hsp sp="1"/>Hypertrophic</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">12 (5)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">
                           <hsp sp="1"/>Non compaction</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">4 (1)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">
                           <hsp sp="1"/>Unclassified</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">3 (1)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Unknown</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">19 (7)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Other</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">13 (5)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <vsp sp="0.5"/>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <italic>Medical history</italic>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Myocardial infarction</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">94 (36)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">PCI</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">82 (31)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">CABG</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">43 (16)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Valvular heart disease</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">136 (53)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Atrial fibrillation</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">105 (40)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Other arrhythmia</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">82 (32)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">ICD</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">151 (59)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">CRT</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">78 (30)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Pacemaker</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">38 (15)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">CVA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">41 (16)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Chronic renal failure</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">136 (53)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Diabetes Mellitus</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">81 (31)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Known hypercholesterolemia</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">93 (35)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Hypertension</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">120 (46)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Sleep apnea</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">26 (10)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <vsp sp="0.5"/>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <italic>Intoxications</italic>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Alcohol consumption (&gt;<hsp sp="0.10"/>1<hsp sp="0.25"/>unit/day)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">108 (42)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Smoking</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">185 (71)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">
                           <hsp sp="1"/>Ever</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">186 (72)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">
                           <hsp sp="1"/>Current</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">26 (10)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <vsp sp="0.5"/>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col2">
                           <italic>Medication use</italic>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">ACE-i</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">173 (67)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">ARB</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">75 (29)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Aldosteron antagonist</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">178 (68)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Diuretic</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">237 (90)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Beta-blocker</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">232(88)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Aspirin</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">45 (17)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Vitamin K antagonist</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">200 (77)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Nitrates</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">44 (17)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Digoxin</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">59 (23)</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Antiarrhythmics</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">39 (15)</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:legend>
                  <ce:simple-para id="sp0025" view="all">Normally distributed continuous variables are presented as mean (±<ce:hsp sp="0.25"/>standard deviation). Non-normally distributed continuous variables are expressed as median (25th–75th percentile). Categorical variables are expressed as count (percentage). Valid percentages may vary for some counts, because of missing values. ACE-I<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>ace inhibitor; ARB<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>angiotensin II receptor blocker; CABG<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>coronary artery bypass grafting; COPD<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>chronic obstructive pulmonary disease; CRP<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>C-reactive protein; CRT<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>cardiac resynchronization therapy; CVA<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>cerebrovascular accident; HFPEF<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>heart failure with preserved ejection fraction; HsTNT<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>high sensitive cardiac troponin T; ICD<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>implantable cardioverter/defibrillator; LVEF<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>left ventricular ejection fraction; NT-proBNP<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>N-terminal pro-B-type natriuretic peptide NYHA<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>New York heart association; PCI<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>percutaneous coronary intervention.</ce:simple-para>
               </ce:legend>
               <ce:table-footnote id="tf0005">
                  <ce:label>a</ce:label>
                  <ce:note-para id="np0005" view="all">Baseline echocardiograms were available in 72% of all patients because of logistic reasons.</ce:note-para>
               </ce:table-footnote>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="t0010" frame="topbot" rowsep="0" colsep="0">
               <ce:label>Table 2</ce:label>
               <ce:caption id="ca0025">
                  <ce:simple-para id="sp0030" view="all">Associations between baseline miRs and the primary endpoint and secondary endpoint.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="al0025">Table 2</ce:alt-text>
               <tgroup cols="5" rowsep="0" colsep="0">
                  <colspec colname="col1"/>
                  <colspec colname="col2"/>
                  <colspec colname="col3"/>
                  <colspec colname="col4"/>
                  <colspec colname="col5"/>
                  <thead>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" colname="col1"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col3" rowsep="1">Primary endpoint</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col4" nameend="col5" rowsep="1">Secondary endpoint</entry>
                     </row>
                     <row valign="top" rowsep="1">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">HR<cross-ref refid="tf0010" id="cf0015">
                              <sup loc="post">⁎</sup>
                           </cross-ref> (95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">P</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">HR (95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">P</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-1254</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">1.01 (0.92–1.09)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.91</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">1.00 (0.91–1.09)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.99</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-22-3p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">1.02 (0.93–1.12)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.61</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">1.00 (0.90–1.09)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.85</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-345-5p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">0.99 (0.89–1.09)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.81</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">0.95 (0.86–1.06)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.38</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-378a-3p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">1.00 (0.91–1.11)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.93</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">0.99 (0.89–1.09)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.77</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-423-5p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">1.01 (0.91–1.11)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.92</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">0.97 (0.87–1.07)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.53</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-486-5p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">1.04 (0.94–1.15)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.47</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">1.00 (0.89–1.11)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.93</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-320a</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">1.04 (0.95–1.13)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.44</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">1.02 (0.93–1.12)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.71</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:legend>
                  <ce:simple-para id="sp0035" view="all">miR<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>microRNA.</ce:simple-para>
                  <ce:simple-para id="sp0040" view="all">Primary endpoint: cardiac death, cardiac transplantation, left ventricular assist device implantation, and hospitalization for the management of acute or worsened heart failure; secondary endpoint: hospitalization for the management of acute or worsened heart failure.</ce:simple-para>
               </ce:legend>
               <ce:table-footnote id="tf0010">
                  <ce:label>⁎</ce:label>
                  <ce:note-para id="np0010" view="all">Hazard ratios (HRs) and corresponding confidence intervals (CIs) were calculated using Cox regression analyses and are given per doubling of level of miR.</ce:note-para>
               </ce:table-footnote>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="t0015" frame="topbot" rowsep="0" colsep="0">
               <ce:label>Table 3</ce:label>
               <ce:caption id="ca0030">
                  <ce:simple-para id="sp0045" view="all">Associations between temporal miR patterns and the primary endpoint.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="al0030">Table 3</ce:alt-text>
               <tgroup cols="15" rowsep="0" colsep="0">
                  <colspec colname="col1"/>
                  <colspec colname="col2"/>
                  <colspec colname="col3"/>
                  <colspec colname="col4"/>
                  <colspec colname="col5"/>
                  <colspec colname="col6"/>
                  <colspec colname="col7"/>
                  <colspec colname="col8"/>
                  <colspec colname="col9"/>
                  <colspec colname="col10"/>
                  <colspec colname="col11"/>
                  <colspec colname="col12"/>
                  <colspec colname="col13"/>
                  <colspec colname="col14"/>
                  <colspec colname="col15"/>
                  <thead>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" colname="col1"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col3" rowsep="1">miR-1254</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col4" nameend="col5" rowsep="1">miR-22-3p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col6" nameend="col7" rowsep="1">miR-345-5p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col8" nameend="col9" rowsep="1">miR-378a-3p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col10" nameend="col11" rowsep="1">miR-423-5p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col12" nameend="col13" rowsep="1">miR-486-5p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col14" nameend="col15" rowsep="1">miR-320a</entry>
                     </row>
                     <row valign="top" rowsep="1">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">HR<cross-ref refid="tf0015" id="cf0020">
                              <sup loc="post">a</sup>
                           </cross-ref>
                           <br/>(95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">HR<cross-ref refid="tf0015" id="cf0025">
                              <sup loc="post">a</sup>
                           </cross-ref>
                           <br/>(95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">HR<cross-ref refid="tf0015" id="cf0030">
                              <sup loc="post">a</sup>
                           </cross-ref>
                           <br/>(95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8">HR<cross-ref refid="tf0015" id="cf0035">
                              <sup loc="post">a</sup>
                           </cross-ref> (95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9">p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col10">HR<cross-ref refid="tf0015" id="cf0040">
                              <sup loc="post">a</sup>
                           </cross-ref>
                           <br/>(95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col11">p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col12">HR<cross-ref refid="tf0015" id="cf0045">
                              <sup loc="post">a</sup>
                           </cross-ref>
                           <br/>(95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col13">p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col14">HR<cross-ref refid="tf0015" id="cf0050">
                              <sup loc="post">a</sup>
                           </cross-ref> (95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col15">p</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col15">
                           <italic>Temporal pattern of miR value</italic>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Adjusted for age<br/>and gender</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">1.02<br/>(0.71–1.26)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.782</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">0.64<br/>(0.47–0.77)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">&lt;<hsp sp="0.10"/>0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">1.01<br/>(0.97–1.04)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">0.624</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8">0.84<br/>(0.69–1.03)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9">0.085</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col10">1.01<br/>(0.97–1.05)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col11">0.800</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col12">1.00<br/>(1.00–1.01)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col13">0.069</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col14">0.92<br/>(0.74–1.19)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col15">0.516</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Multivariable<br/>adjusted<cross-ref refid="tf0020" id="cf0055">
                              <sup loc="post">b</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">0.97<br/>(0.78–1.22)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.757</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">0.71<br/>(0.44–0.94)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.005</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">1.00<br/>(0.97–1.03)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">0.921</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8">0.88<br/>(0.71–1.06)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9">0.148</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col10">1.00<br/>(0.95–1.08)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col11">0.845</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col12">1.00<br/>0.99–1.01)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col13">0.380</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col14">1.01<br/>(0.78–1.22)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col15">0.896</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col15">
                           <vsp sp="0.5"/>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col15">
                           <italic>Slope of temporal pattern</italic>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Adjusted for age<br/>and gender</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">1.29<br/>(0.75–2.49)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.456</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">0.20<br/>(0.09–0.50)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">&lt;<hsp sp="0.10"/>0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col10">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col11">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col12">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col13">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col14">0.51<br/>(0.29–0.90)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col15">0.012</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Multivariable<br/>adjusted<cross-ref refid="tf0020" id="cf0060">
                              <sup loc="post">b</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">1.30<br/>(0.79-2.35)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.288</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">0.33<br/>(0.20–0.51)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">&lt;<hsp sp="0.10"/>0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col10">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col11">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col12">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col13">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col14">0.59<br/>(0.33–1.12)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col15">0.102</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col15">
                           <vsp sp="0.5"/>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col15">
                           <italic>Area under the curve of temporal pattern</italic>
                        </entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Adjusted for age<br/>and gender</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">1.09<br/>(0.97–1.27)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.206</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">1.00<br/>(0.80–1.14)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.898</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col10">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col11">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col12">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col13">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col14">1.16<br/>(0.94–1.42)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col15">0.257</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">Multivariable<br/>adjusted<cross-ref refid="tf0020" id="cf0065">
                              <sup loc="post">b</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">1.26<br/>(0.95–1.53)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.100</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">0.99<br/>(0.88–0.17)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.846</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col10">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col11">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col12">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col13">NA</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col14">1.19<br/>(0.88–1.44)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col15">0.330</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:legend>
                  <ce:simple-para id="sp0050" view="all">miR<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>microRNA.</ce:simple-para>
               </ce:legend>
               <ce:table-footnote id="tf0015">
                  <ce:label>a</ce:label>
                  <ce:note-para id="np0015" view="all">Hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) are given per doubling of value, slope or area under the curve at any point in time.</ce:note-para>
               </ce:table-footnote>
               <ce:table-footnote id="tf0020">
                  <ce:label>b</ce:label>
                  <ce:note-para id="np0020" view="all">Adjusted for age, gender, New York Heart Association class and ischemic cardiomyopathy.</ce:note-para>
               </ce:table-footnote>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="t0020" frame="topbot" rowsep="0" colsep="0">
               <ce:label>Table 4</ce:label>
               <ce:caption id="ca0035">
                  <ce:simple-para id="sp0055" view="all">Associations between repeatedly measured miRs and B-type natriuretic peptide, high sensitive cardiac troponin T and C- reactive protein.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="al0035">Table 4</ce:alt-text>
               <tgroup cols="7" rowsep="0" colsep="0">
                  <colspec colname="col1"/>
                  <colspec colname="col2"/>
                  <colspec colname="col3"/>
                  <colspec colname="col4"/>
                  <colspec colname="col5"/>
                  <colspec colname="col6"/>
                  <colspec colname="col7"/>
                  <thead>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" colname="col1"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col3" rowsep="1">NT-proBNP</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col4" nameend="col5" rowsep="1">HsTNT</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col6" nameend="col7" rowsep="1">CRP</entry>
                     </row>
                     <row valign="top" rowsep="1">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">Beta coefficient (95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">P</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">Beta coefficient (95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">P</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">Beta coefficient (95% CI)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">P</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-1254</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">0.07 (−<hsp sp="0.10"/>0.05–0.02)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.27</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">0.00 (−<hsp sp="0.10"/>0.01–0.01)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.59</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">0.00 (−<hsp sp="0.10"/>0.02–0.02)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">0.92</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-22-3p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">−<hsp sp="0.10"/>0.01 (−<hsp sp="0.10"/>0.022 to −<hsp sp="0.10"/>0.00)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.14</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">−<hsp sp="0.10"/>0.01 (−<hsp sp="0.10"/>0.02 to −<hsp sp="0.10"/>0.00)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.014</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">−<hsp sp="0.10"/>0.03 (−<hsp sp="0.10"/>0.06–0.00)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">0.051</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-345-5p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">−<hsp sp="0.10"/>0.04 (−<hsp sp="0.10"/>0.02–0.01)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.57</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">−<hsp sp="0.10"/>0.01 (−<hsp sp="0.10"/>0.02–0.01)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.35</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">−<hsp sp="0.10"/>0.04 (−<hsp sp="0.10"/>0.07 to −<hsp sp="0.10"/>0.01)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">0.012</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-378a-3p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">−<hsp sp="0.10"/>0.01 (−<hsp sp="0.10"/>0.02–0.00)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.12</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">0.00 (−<hsp sp="0.10"/>0.01–0.01)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.91</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">−<hsp sp="0.10"/>0.02 (−<hsp sp="0.10"/>0.04–0.01)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">0.27</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-423-5p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">0.00 (−<hsp sp="0.10"/>0.02–0.01)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.81</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">−<hsp sp="0.10"/>0.01 (−<hsp sp="0.10"/>0.02–0.00)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.17</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">−<hsp sp="0.10"/>0.01 (−<hsp sp="0.10"/>0.04–0.03)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">0.63</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-486-5p</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">−<hsp sp="0.10"/>0.01 (−<hsp sp="0.10"/>0.02–0.01)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.43</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">−<hsp sp="0.10"/>0.01 (−<hsp sp="0.10"/>0.02–0.01)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.37</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">−<hsp sp="0.10"/>0.03 (−<hsp sp="0.10"/>0.06–0.00)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">0.070</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" role="rowhead">miR-320a</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2">0.00 (−<hsp sp="0.10"/>0.01–0.02)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3">0.69</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4">0.00 (−<hsp sp="0.10"/>0.01–0.01)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5">0.74</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6">0.01 (−<hsp sp="0.10"/>0.02–0.03)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7">0.71</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:legend>
                  <ce:simple-para id="sp0060" view="all">Beta coefficients and corresponding 95% confidence intervals (CIs) were calculated using generalised estimating equations with 10log transformed microRNAs (miRs) as independent variables and 10log transformed N-terminal pro-B-type natriuretic peptide (NT-proBNP), high sensitive cardiac troponin T (HsTNT) and C-reactive protein (CRP) as dependent variables.</ce:simple-para>
               </ce:legend>
            </ce:table>
         </ce:floats>
         <head>
            <ce:title id="ti0005">Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study</ce:title>
            <ce:author-group id="ag0005">
               <ce:author orcid="0000-0003-3749-9303" id="au0005" author-id="S0167527317311075-30af7b7e595dabc145762dcf34b6d471">
                  <ce:given-name>Nick</ce:given-name>
                  <ce:surname>van Boven</ce:surname>
                  <ce:cross-ref refid="af0005" id="cf0070">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0010" author-id="S0167527317311075-2ff4e2d70b259d167f529a74c4f745e0">
                  <ce:given-name>K. Martijn</ce:given-name>
                  <ce:surname>Akkerhuis</ce:surname>
                  <ce:cross-ref refid="af0010" id="cf0075">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0015" author-id="S0167527317311075-784c2cde30b6fcf6634fa4028684aeca">
                  <ce:given-name>Sharda S.</ce:given-name>
                  <ce:surname>Anroedh</ce:surname>
                  <ce:cross-ref refid="af0010" id="cf0080">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0020" author-id="S0167527317311075-ef691147cf807c3bd529149379e833ca">
                  <ce:given-name>Dimitris</ce:given-name>
                  <ce:surname>Rizopoulos</ce:surname>
                  <ce:cross-ref refid="af0015" id="cf0085">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0025" author-id="S0167527317311075-61c229431f535fa8ad42ed15ee50b9ff">
                  <ce:given-name>Yigal</ce:given-name>
                  <ce:surname>Pinto</ce:surname>
                  <ce:cross-ref refid="af0020" id="cf0090">
                     <ce:sup loc="post">d</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0030" author-id="S0167527317311075-02bffa062a3851e6d0119963d0bba32e">
                  <ce:given-name>Linda C.</ce:given-name>
                  <ce:surname>Battes</ce:surname>
                  <ce:cross-ref refid="af0010" id="cf0095">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0035" author-id="S0167527317311075-1a1b1ec39d31b81bf032eb8a28f8afca">
                  <ce:given-name>Hans L.</ce:given-name>
                  <ce:surname>Hillege</ce:surname>
                  <ce:cross-ref refid="af0025" id="cf0100">
                     <ce:sup loc="post">e</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0040" author-id="S0167527317311075-39733189f9ece47fc576cc21b0d6c840">
                  <ce:given-name>Kadir C.</ce:given-name>
                  <ce:surname>Caliskan</ce:surname>
                  <ce:cross-ref refid="af0010" id="cf0105">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0045" author-id="S0167527317311075-4328097e2bee9cff36d1c83ba69272c3">
                  <ce:given-name>Tjeerd</ce:given-name>
                  <ce:surname>Germans</ce:surname>
                  <ce:cross-ref refid="af0005" id="cf0110">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0050" author-id="S0167527317311075-92b5f079794dfdf2949c14e55334c4a3">
                  <ce:given-name>Olivier C.</ce:given-name>
                  <ce:surname>Manintveld</ce:surname>
                  <ce:cross-ref refid="af0010" id="cf0115">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0055" author-id="S0167527317311075-c47783eed028e7df1f2a905ad36bfd0a">
                  <ce:given-name>Jan-Hein</ce:given-name>
                  <ce:surname>Cornel</ce:surname>
                  <ce:cross-ref refid="af0005" id="cf0120">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0060" author-id="S0167527317311075-e1861c31f03b691ef91736bf45d190d5">
                  <ce:given-name>Alina A.</ce:given-name>
                  <ce:surname>Constantinescu</ce:surname>
                  <ce:cross-ref refid="af0010" id="cf0125">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0065" author-id="S0167527317311075-66ec411141c45f39d6e483ce82130b71">
                  <ce:given-name>Eric</ce:given-name>
                  <ce:surname>Boersma</ce:surname>
                  <ce:cross-ref refid="af0010" id="cf0130">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0070" author-id="S0167527317311075-cbd057f35edf6d36618b3ae963d334c4">
                  <ce:given-name>Victor A.</ce:given-name>
                  <ce:surname>Umans</ce:surname>
                  <ce:cross-ref refid="af0005" id="cf0135">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au0075" author-id="S0167527317311075-9bcac7d595290beb992c59a4c48046f6">
                  <ce:given-name>Isabella</ce:given-name>
                  <ce:surname>Kardys</ce:surname>
                  <ce:cross-ref refid="af0010" id="cf0140">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="cr0005" id="cf0145">
                     <ce:sup loc="post">⁎</ce:sup>
                  </ce:cross-ref>

               </ce:author>
               <ce:affiliation id="af0005">
                  <ce:label>a</ce:label>
                  <ce:textfn id="tn0005">Cardiology, Medical Centre Alkmaar, Alkmaar, The Netherlands</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Cardiology</sa:organization>
                     <sa:organization>Medical Centre Alkmaar</sa:organization>
                     <sa:city>Alkmaar</sa:city>
                     <sa:country>The Netherlands</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="af0010">
                  <ce:label>b</ce:label>
                  <ce:textfn id="tn0010">Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Cardiology</sa:organization>
                     <sa:organization>Erasmus Medical Centre</sa:organization>
                     <sa:city>Rotterdam</sa:city>
                     <sa:country>The Netherlands</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="af0015">
                  <ce:label>c</ce:label>
                  <ce:textfn id="tn0015">Biostatistics, Erasmus Medical Centre, Rotterdam, The Netherlands</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Biostatistics</sa:organization>
                     <sa:organization>Erasmus Medical Centre</sa:organization>
                     <sa:city>Rotterdam</sa:city>
                     <sa:country>The Netherlands</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="af0020">
                  <ce:label>d</ce:label>
                  <ce:textfn id="tn0020">Cardiology, Academic Medical Centre, Amsterdam, The Netherlands</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Cardiology</sa:organization>
                     <sa:organization>Academic Medical Centre</sa:organization>
                     <sa:city>Amsterdam</sa:city>
                     <sa:country>The Netherlands</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="af0025">
                  <ce:label>e</ce:label>
                  <ce:textfn id="tn0025">Cardiology, University Medical Centre Groningen, Groningen, The Netherlands</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Cardiology</sa:organization>
                     <sa:organization>University Medical Centre Groningen</sa:organization>
                     <sa:city>Groningen</sa:city>
                     <sa:country>The Netherlands</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:correspondence id="cr0005">
                  <ce:label>⁎</ce:label>
                  <ce:text id="tx0005">Corresponding author at: Department of Cardiology, Erasmus Medical Centre, room Ba-561, 's Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.</ce:text>
                  <sa:affiliation>
                     <sa:organization>Department of Cardiology</sa:organization>
                     <sa:organization>Erasmus Medical Centre</sa:organization>
                     <sa:address-line>room Ba-561, 's Gravendijkwal 230</sa:address-line>
                     <sa:city>CE Rotterdam</sa:city>
                     <sa:postal-code>3015</sa:postal-code>
                     <sa:country>The Netherlands</sa:country>
                  </sa:affiliation>
               </ce:correspondence>
            </ce:author-group>
            <ce:date-received day="5" month="8" year="2016"/>
            <ce:date-revised day="15" month="1" year="2017"/>
            <ce:date-accepted day="20" month="2" year="2017"/>
            <ce:abstract id="ab0005" xml:lang="en" view="all" class="author">
                <ce:abstract-sec id="as0005" view="all">
                  <ce:section-title id="st0010">Background</ce:section-title>
                  <ce:simple-para id="sp0065" view="all">Several studies have suggested circulating microRNAs (miRs) are associated with heart failure, but these studies were small, and limited to single miR measurements.</ce:simple-para>
                  <ce:simple-para id="sp0070" view="all">We examined 7 miRs which were previously linked to heart failure, and tested whether their temporal expression level predicts prognosis in a prospective cohort of chronic heart failure (CHF) patients.</ce:simple-para>
               </ce:abstract-sec>
                <ce:abstract-sec id="as0010" view="all">
                  <ce:section-title id="st0015">Methods and results</ce:section-title>
                  <ce:simple-para id="sp0075" view="all">In 2011–2013, 263 CHF patients were included. At inclusion and subsequently every 3<ce:hsp sp="0.25"/>months, we measured 7<ce:hsp sp="0.25"/>miRs. The primary endpoint (PE) comprised heart failure hospitalization, cardiovascular mortality, cardiac transplantation and LVAD implantation. Associations between temporal miR patterns and the PE were investigated by joint modelling, which combines mixed models with Cox regression.</ce:simple-para>
                  <ce:simple-para id="sp0080" view="all">Mean age was 67<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>13<ce:hsp sp="0.25"/>years, 72% were men and 27% NYHA classes III–IV. We obtained 873 blood samples (median 3 [IQR 2–5] per patient). The PE was reached in 41 patients (16%) during a median follow-up of 0.9 [0.6–1.4] years. The temporal pattern of miR-22-3p was independently associated with the PE (HR [95% CI] per doubling of level: 0.64 [0.47–0.77]). The instantaneous change in level (slope of the temporal miR pattern) of miR-22-3p was also independently associated with the PE (HR [95% CI] per doubling of slope: 0.33 [0.20–0.51]). These associations remained statistically significant after adjustment for temporal patterns of NT-proBNP, Troponin T and CRP.</ce:simple-para>
               </ce:abstract-sec>
                <ce:abstract-sec id="as0015" view="all">
                  <ce:section-title id="st0020">Conclusions</ce:section-title>
                  <ce:simple-para id="sp0085" view="all">The temporal pattern of circulating miR-22-3p contains important prognostic and independent information in CHF patients. This concept warrants further investigation in larger series with extended follow-up.</ce:simple-para>
               </ce:abstract-sec>
            </ce:abstract>
            <ce:keywords id="ks0005" view="all" class="keyword">
               <ce:section-title id="st0025">Keywords</ce:section-title>
               <ce:keyword id="kw0005">
                  <ce:text id="tx0010">MicroRNAs</ce:text>
               </ce:keyword>
               <ce:keyword id="kw0010">
                  <ce:text id="tx0015">Biomarkers</ce:text>
               </ce:keyword>
               <ce:keyword id="kw0015">
                  <ce:text id="tx0020">Chronic heart failure</ce:text>
               </ce:keyword>
               <ce:keyword id="kw0020">
                  <ce:text id="tx0025">Prognostication</ce:text>
               </ce:keyword>
               <ce:keyword id="kw0025">
                  <ce:text id="tx0030">Mortality</ce:text>
               </ce:keyword>
            </ce:keywords>
         </head>
         <body view="all">
            <ce:sections>
               <ce:section id="s0005" view="all">
                  <ce:label>1</ce:label>
                  <ce:section-title id="st0030">Introduction</ce:section-title>
                  <ce:para id="p0005" view="all">Contemporary treatment of chronic heart failure ((C)HF) generally aims to stabilize or at least decelerate disease progression. Adjustment of pharmacotherapy is largely based on clinical judgement and thus mostly relies on the worsening of symptoms or signs <ce:cross-refs id="cf0150" refid="bb0005 bb0010">[1,2]</ce:cross-refs>. However, in the context of the complexity of HF therapy, considerable clinical skills, as well as cooperation of the patients, are required to recognize opportunities to titrate therapies and to implement such changes intervene early and timely <ce:cross-ref id="cf0155" refid="bb0015">[3]</ce:cross-ref>. Consequently, higher-risk patients may be undertreated <ce:cross-ref id="cf0160" refid="bb0015">[3]</ce:cross-ref>. Blood biomarkers have the potential to monitor subtle changes in the heart that reflect and possibly predict adverse changes before they become clinically apparent or reported <ce:cross-ref id="cf0165" refid="bb0020">[4]</ce:cross-ref>. The value of biomarkers, such as B-type natriuretic peptides (BNP), cardiac troponins and C-reactive protein (CRP), for risk stratification of CHF patients has already been demonstrated <ce:cross-refs id="cf0170" refid="bb0025 bb0030 bb0035 bb0040">[5–8]</ce:cross-refs>. Moreover, natriuretic peptide-guided HF therapy has recently been given a class IIa recommendation in US HF guidelines to achieve guideline-directed medical therapy <ce:cross-refs id="cf0175" refid="bb0010 bb0045">[2,9]</ce:cross-refs>.</ce:para>
                  <ce:para id="p0010" view="all">Nevertheless, the predictive capability of the aforementioned biomarkers for worsening of CHF still leaves room for improvement. MicroRNAs (miRs) are upcoming novel biomarkers that seem promising for early diagnosis and treatment of HF. MiRs are non-coding, ~<ce:hsp sp="0.10"/>22 nucleotide long RNA sequences, which target messenger RNAs for cleavage or translational repression and thereby influence a great variety of biological processes <ce:cross-ref id="cf0180" refid="bb0050">[10]</ce:cross-ref>. The stability of miRs in plasma, and consequently their reliable assessment in easily accessible samples, potentially makes them attractive biomarkers for a wide range of diseases <ce:cross-ref id="cf0185" refid="bb0055">[11]</ce:cross-ref>. Studies revealing that deletion of Dicer, a gene encoding an RNase III endonuclease essential for miR processing, leads to cardiac remodelling and dilation, were the first to show involvement of miRs in HF <ce:cross-refs id="cf0190" refid="bb0060 bb0065">[12,13]</ce:cross-refs> and to suggest that miRs might be used as biomarkers for cardiovascular diseases <ce:cross-ref id="cf0195" refid="bb0070">[14]</ce:cross-ref>. Several other studies have subsequently shown associations between miRs and myocardial infarction <ce:cross-refs id="cf0200" refid="bb0075 bb0080 bb0085 bb0090">[15–18]</ce:cross-refs> and HF <ce:cross-refs id="cf0205" refid="bb0095 bb0100 bb0105 bb0110 bb0115 bb0120">[19–24]</ce:cross-refs>. However, most studies pertaining to HF were performed in case-control settings and had a limited sample size. Furthermore, these studies usually assessed miRs only once. Repeated, longitudinal miR assessment in CHF patients may, however, provide insight into individual, temporal patterns and the patient's ensuing risk of disease progression. The temporal patterns of miRs in patients with known CHF have not yet been investigated.</ce:para>
                  <ce:para id="p0015" view="all">In the current prospective, observational study, we have performed frequent (up to 8), repeated measurements of multiple miRs that were previously linked to HF (miR-1254, miR-22-3p, miR-423-5p, miR-486-5p and miR-320a) or have been shown to be cardiac-enriched (miR-345-5p, miR-378a-3p) in a cohort of 263 outpatients with CHF, and have subsequently investigated the associations of the obtained temporal patterns with adverse clinical outcome during follow-up.</ce:para>
               </ce:section>
               <ce:section id="s0010" role="materials-methods" view="all">
                  <ce:label>2</ce:label>
                  <ce:section-title id="st0035">Methods</ce:section-title>
                  <ce:section id="s0015" view="all">
                     <ce:label>2.1</ce:label>
                     <ce:section-title id="st0040">Patients</ce:section-title>
                     <ce:para id="p0020" view="all">The <ce:italic>Serial biomarker measurements and new echocardiographic techniques in chronic heart failure patients result in tailored prediction of prognosis</ce:italic> (Bio-SHiFT) study was designed to investigate the relationship between temporal patterns of biomarkers involved in CHF and prognosis. Bio-SHiFT is an ongoing prospective, observational study of stable outpatients with CHF, conducted in Erasmus MC, Rotterdam, The Netherlands and Medical Centre Alkmaar, The Netherlands. Patients were recruited during their regular outpatient visits and were in clinically stable condition. Patients were eligible for inclusion if aged 18<ce:hsp sp="0.25"/>years or older, capable of understanding and signing informed consent, and if CHF (including HF with preserved ejection fraction (HFPEF)) was diagnosed ≥<ce:hsp sp="0.10"/>3<ce:hsp sp="0.25"/>months ago according to the guidelines of the European Society of Cardiology (ESC) <ce:cross-refs id="cf0210" refid="bb0125 bb0130 bb0135">[25–27]</ce:cross-refs>. Detailed inclusion and exclusion criteria are shown in <ce:cross-ref id="cf0215" refid="f0005">Fig. 1</ce:cross-ref>
                        <ce:float-anchor refid="f0005"/>. The study was approved by the medical ethics committees of the participating hospitals and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all patients.The study is registered in ClinicalTrials.gov, number NCT01851538. In the current paper, we have performed an analysis on the 263 patients who were enrolled during the first inclusion period between October 2011 and June 2013. Follow-up for this analysis lasted from October 2011 until November 2013.</ce:para>
                  </ce:section>
                  <ce:section id="s0020" view="all">
                     <ce:label>2.2</ce:label>
                     <ce:section-title id="st0045">Baseline assessment</ce:section-title>
                     <ce:para id="p0025" view="all">At baseline patients were evaluated by trained research physicians, who collected information on HF related symptoms including NYHA class <ce:cross-refs id="cf0220" refid="bb0125 bb0130">[25,26]</ce:cross-refs> and performed a physical examination, including blood pressure, heart rate and body mass index. Information on aetiology of heart failure, presence of systolic dysfunction, cardiovascular risk factors, medical history and medical treatment was retrieved primarily from hospital records and was completed by anamnesis in case of ambiguities. History of myocardial infarction, percutaneous coronary intervention (PCI), coronary artery bypass grafting, valvular heart disease, atrial fibrillation or other arrhythmias, device implantation, cerebrovascular accident, diabetes mellitus, hypercholesterolemia, hypertension, and sleep apnea were defined as a clinical diagnosis of these conditions, as reported by the treating physician in the medical chart. History of chronic renal failure was defined as glomerular filtration rate less than 60<ce:hsp sp="0.25"/>mL/min/1.73<ce:hsp sp="0.25"/>m<ce:sup loc="post">2</ce:sup>. Alcohol consumption was defined as drinking ≥<ce:hsp sp="0.10"/>1 alcoholic consumption per day. Electrocardiography and echocardiography were performed. Data were entered into electronic case report forms. Non-fasting blood and urine samples were collected.</ce:para>
                  </ce:section>
                  <ce:section id="s0025" view="all">
                     <ce:label>2.3</ce:label>
                     <ce:section-title id="st0050">Follow-up visits</ce:section-title>
                     <ce:para id="p0030" view="all">All patients continued routine outpatient visits during the study. Study follow-up visits were scheduled every 3<ce:hsp sp="0.25"/>months (a window of ±<ce:hsp sp="0.10"/>1<ce:hsp sp="0.25"/>month was allowed), for a maximum of 30<ce:hsp sp="0.25"/>months. For patients' convenience, study visits and routine outpatient visits were combined when possible. At each tri-monthly study visit, a short medical evaluation was performed and blood and urine samples were collected. Adverse cardiovascular events and changes in medication were recorded in electronic case report forms.</ce:para>
                  </ce:section>
                  <ce:section id="s0030" view="all">
                     <ce:label>2.4</ce:label>
                     <ce:section-title id="st0055">Blood sampling and miR measurement</ce:section-title>
                     <ce:para id="p0035" view="all">Blood samples were collected at baseline and at each follow-up visit, and were processed and stored locally at a temperature of −<ce:hsp sp="0.10"/>80<ce:hsp sp="0.25"/>°C within 2<ce:hsp sp="0.25"/>h after blood collection. When applicable, samples were transported to the central laboratory (Erasmus MC, Rotterdam, The Netherlands) under controlled conditions (at a temperature of −<ce:hsp sp="0.10"/>80<ce:hsp sp="0.25"/>°C), until batch analysis took place. Accordingly, results of the biomarker assays were not available to treating physicians at the time of the outpatient visits. Thus, the biomarker measurements did not lead to treatment adjustments, and all patients received usual care based on European guidelines <ce:cross-refs id="cf0225" refid="bb0125 bb0130">[25,26]</ce:cross-refs>.</ce:para>
                     <ce:para id="p0040" view="all">For the purpose of the current investigation, stored plasma samples were transported under controlled conditions to ACS Biomarker, Amsterdam, The Netherlands, and seven miRs were measured in one batch: miR-1254, miR-22-3p, miR-345-5p, miR-378a-3p, miR-423-5p, miR-486-5p and miR320a. MiR-1254, miR-22-3p, miR-423-5p, miR-486-5p and miR-320a were selected because they were associated with HF in previous studies <ce:cross-refs id="cf0230" refid="bb0055 bb0105 bb0120">[11,21,24]</ce:cross-refs>. MiR-378a-3p and miR-345-5p were selected because of their presence in cardiomyocytes <ce:cross-ref id="cf0235" refid="bb0140">[28]</ce:cross-ref>. Plasma was thawed on ice and RNA isolation was performed using the TRIZOL LS reagent (Life Technology) according to the manufacturer's protocol, with a starting volume of 200<ce:hsp sp="0.25"/>μl plasma. Subsequently, 8<ce:hsp sp="0.25"/>μl of the eluate from the RNA isolation was used for the reverse transcription reaction. The transcription followed the manufacturer's protocol of the miScript Reverse Transcription Kit (Qiagen). For real-time PCR, 2<ce:hsp sp="0.25"/>μl of 10<ce:hsp sp="0.10"/>× diluted cDNA was used in a total volume of 10<ce:hsp sp="0.25"/>μll. The real-time PCR reaction was performed on a LightCycler 480 using the following program: 5<ce:hsp sp="0.25"/>min of pre-incubation at 95<ce:hsp sp="0.25"/>°C; 10<ce:hsp sp="0.25"/>s of denaturation at 95<ce:hsp sp="0.25"/>°C, 20<ce:hsp sp="0.25"/>s of annealing at 58<ce:hsp sp="0.25"/>°C and 30<ce:hsp sp="0.25"/>s of elongation at 72<ce:hsp sp="0.25"/>°C, in a total of 45 cycles. Data were analysed with LinRegPCR quantitative PCR data analysis software. MiR values were normalized using exogenous <ce:italic>C. elegans</ce:italic> miR-39 as a spike-in control, which was applied prior to the RNA isolation step. The forward primers used were: miR-423-5p: TGAGGGGCAGAGAGCGAGACTTT; miR-22-3p: AAGCTGCCAGTTGAAGAACTGT; miR-378a-3p: ACTGGACTTGGAGTCAGAAGG; miR-1254: CTGGAAGCTGGAGCCTGC; miR-345-5p: GCTGACTCCTAGTCC; miR-486-5p: TCCTGTACTGAGCTG; miR-320a: AAAAGCTGGGTTGAGAGGGCGA.</ce:para>
                     <ce:para id="p0045" view="all">Batch analysis of N-terminal pro B-type natriuretic peptide (NT-proBNP), high-sensitive cardiac troponin T (HsTNT) and C-reactive protein was performed in the Clinical Chemistry Laboratory of the Erasmus MC, Plasma NT–proBNP and cardiac Troponin T were analysed using electrochemiluminesence immunoassays (Roche Diagnostics, Elecsys 2010, Indianapolis, Indiana, USA), measuring concentrations ranging from 5 to 35,000<ce:hsp sp="0.25"/>ng/l and 3 to 10,000<ce:hsp sp="0.25"/>ng/l, respectively. CRP was measured using an immunoturbidimetric assay (Roche Hitachi 912 chemistry analyser, Basel, Switzerland), which measures concentrations ranging from 0.3 to 350<ce:hsp sp="0.25"/>mg/l.</ce:para>
                  </ce:section>
                  <ce:section id="s0035" view="all">
                     <ce:label>2.5</ce:label>
                     <ce:section-title id="st0060">Clinical study endpoints</ce:section-title>
                     <ce:para id="p0050" view="all">During follow-up, endpoints were recorded in the electronic case report forms by trained research physicians, and associated hospital records and discharge letters were collected. A clinical event committee blinded to the biomarker results subsequently reviewed all collected information and adjudicated primary and secondary endpoints.</ce:para>
                     <ce:para id="p0055" view="all">The primary endpoint comprised the composite of cardiac death, cardiac transplantation, left ventricular assist device implantation, and hospitalization for the management of acute or worsened HF. Secondary endpoints included individual components of the primary endpoint, as well as myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting, cerebrovascular accident, and all-cause mortality.</ce:para>
                     <ce:para id="p0060" view="all">Cardiac death was defined as death from myocardial infarction or other ischemic heart disease (ICD-10: I20–I25), death from other heart disease including HF (I30–I45 and I47–I52), sudden cardiac death (I46), sudden death undefined (R96) or unwitnessed or ill-described death (R98, R99). Hospitalisation for acute or worsened HF was defined as exacerbation of symptoms typical of HF, in combination with 2 of the following: BNP or NT-proBNP &gt;<ce:hsp sp="0.10"/>3<ce:hsp sp="0.10"/>× ULN, signs of worsening HF, such as pulmonary rales, raised jugular venous pressure or peripheral oedema, increased dose or intravenous administration of diuretics, or administration of positive inotropic agents.</ce:para>
                  </ce:section>
                  <ce:section id="s0040" view="all">
                     <ce:label>2.6</ce:label>
                     <ce:section-title id="st0065">Statistical analysis</ce:section-title>
                     <ce:para id="p0065" view="all">Distributions of continuous variables, including biomarker and miR concentrations, were tested for normality using the Kolmogorov-Smirnov test. Variables with normal distributions are presented as mean<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>SD. Variables with non-normal distributions are presented as median and interquartile range (IQR). Categorical data are displayed as count and percentage.</ce:para>
                     <ce:para id="p0070" view="all">In case of skewed distributions, continuous variables were logarithmically transformed for further analyses. Associations between temporal patterns of each separate miR and the primary endpoint were assessed using a joint modelling approach, which combines a linear mixed-effects model for the serial miR measurements with a Cox proportional hazards model for the occurrence of the primary endpoint. Results are presented as hazard ratios (HRs) per doubling of the miR concentration at any point in time, along with the corresponding 95% CIs. All analyses were adjusted for age and gender. Subsequently, additional multivariable adjustment for potential confounding variables was performed. For this purpose, associations between patient characteristics and baseline miR levels, as well as associations between patient characteristics and the primary endpoint, were identified using univariable linear- or Cox regression analyses, when appropriate. All characteristics associated with the miRs or the primary endpoint were subsequently used as covariates in the mixed-effects and Cox models used to construct the joint models. Adjustment for repeatedly assessed NYHA class was performed by entering NYHA class as a time-dependent variable into the joint model.</ce:para>
                     <ce:para id="p0075" view="all">The above-described analysis assesses the predictive value of the temporal pattern of the actual miR measurements. However, additional features of the miR's trajectory may better predict the primary endpoint <ce:cross-refs id="cf0240" refid="bb0145 bb0150">[29,30]</ce:cross-refs>. Therefore, we investigated whether the instantaneous rate of change in miR (slope of the miR trajectory) is associated with the risk of the primary endpoint. Furthermore, to assess the predictive value of long-term elevation of miR levels, we investigated the associations between the area under the miRs' trajectory and the primary endpoint. This area can be considered as a weighted average of the total longitudinal profile of each patient. The results are presented as HRs per doubling of the area at any point in time, with 95% CIs.</ce:para>
                     <ce:para id="p0080" view="all">Subsequently, we assessed whether the predictive value of the temporal miR patterns was independent of temporal patterns of NT-proBNP, HsTNT and CRP. For this purpose, all individual temporal miR patterns (of miRs significantly associated with the primary endpoint), as well as NT-proBNP, HsTNT and CRP patterns, derived from the adjusted joint models were saved and subsequently entered simultaneously as time-varying covariates into an extended Cox analysis. The same approach was used to investigate the independent predictive value of the slope and the area under the curve of the temporal miR patterns associated with the primary endpoint.</ce:para>
                     <ce:para id="p0085" view="all">To investigate the associations between repeated miR measurements and repeated NT-proBNP, HsTNT and CRP measurements, we used generalised estimating equations. Herewith, we examined whether the miR level at a certain time-point is associated with the level of the other biomarkers at that same time-point.</ce:para>
                     <ce:para id="p0090" view="all">All analyses were performed with R Statistical Software using package JM <ce:cross-refs id="cf0245" refid="bb0145 bb0150">[29,30]</ce:cross-refs>. All tests were two-tailed and p-values<ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.05 were considered statistically significant.</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="s0045" view="all">
                  <ce:label>3</ce:label>
                  <ce:section-title id="st0070">Result</ce:section-title>
                  <ce:section id="s0050" view="all">
                     <ce:label>3.1</ce:label>
                     <ce:section-title id="st0075">Baseline characteristics</ce:section-title>
                     <ce:para view="extended" id="p0095">From October 2011 to June 2013, 263 patients were included. Mean age was 67<ce:hsp sp="0.25"/>years (SD<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>13), 72% were men, and 73% were in New York Heart Association (NYHA) class I or II (<ce:cross-ref id="cf0250" refid="t0005">Table 1</ce:cross-ref>
                        <ce:float-anchor refid="t0005"/>). Median baseline NT-proBNP was 139.6<ce:hsp sp="0.25"/>pmol/L (IQR 51.9–272.9), HsTNT 18.0<ce:hsp sp="0.25"/>ng/l (IQR 9.6–33.2) and CRP 2.2<ce:hsp sp="0.25"/>mg/l (IQR 0.9–4.8). Median duration of HF at inclusion was 4.6<ce:hsp sp="0.25"/>years (IQR 1.7–9.9). Associations between patient characteristics and baseline miR measurements are presented in the <ce:cross-ref refid="ec0005" id="cf0255">Supplementary table</ce:cross-ref>. Of note is the presence of a significant association between ischemic cardiomyopathy (ICM) and several miRs. This is further illustrated in <ce:cross-ref id="cf0260" refid="f0010">Fig. 2</ce:cross-ref>
                        <ce:float-anchor refid="f0010"/>. No significant associations were present with other baseline characteristics.</ce:para>
                     <ce:para view="compact-standard" id="p0100">From October 2011 to June 2013, 263 patients were included. Mean age was 67<ce:hsp sp="0.25"/>years (SD<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>13), 72% were men, and 73% were in New York Heart Association (NYHA) class I or II (<ce:cross-ref id="cf0265" refid="t0005">Table 1</ce:cross-ref>). Median baseline NT-proBNP was 139.6<ce:hsp sp="0.25"/>pmol/L (IQR 51.9–272.9), HsTNT 18.0<ce:hsp sp="0.25"/>ng/l (IQR 9.6–33.2) and CRP 2.2<ce:hsp sp="0.25"/>mg/l (IQR 0.9–4.8). Median duration of HF at inclusion was 4.6<ce:hsp sp="0.25"/>years (IQR 1.7–9.9). Associations between patient characteristics and baseline miR measurements are presented in the Supplementary table. Of note is the presence of a significant association between ischemic cardiomyopathy (ICM) and several miRs. This is further illustrated in <ce:cross-ref id="cf0270" refid="f0010">Fig. 2</ce:cross-ref>. No significant associations were present with other baseline characteristics.</ce:para>
                  </ce:section>
                  <ce:section id="s0055" view="all">
                     <ce:label>3.2</ce:label>
                     <ce:section-title id="st0080">Clinical endpoints</ce:section-title>
                     <ce:para id="p0105" view="all">The primary, composite endpoint was reached by 41 patients (16%), during a median follow-up of 0.9 [0.6–1.4] years: 5 patients died from a cardiovascular cause, 35 patients were re-hospitalized for worsened HF and 1 patient underwent heart transplantation. Of the 35 patients reaching the primary endpoint because of re-hospitalisation for HF, 16 patients died eventually during further follow-up, of whom 12 died from a cardiovascular cause. Overall all-cause mortality was thus 21 (8.0%).</ce:para>
                     <ce:para id="p0110" view="all">Of all baseline variables, NYHA class (HR 1.98; CI 1.24–3.16 for III/IV vs I/II), baseline NT-proBNP (HR per two-fold difference of baseline NT-proBNP 1.42; CI 1.09–1.86), and baseline CRP (HR per two-fold difference of baseline CRP 1.29; CI 1.05–1.60) were independently associated with the primary endpoint. As shown in <ce:cross-ref id="cf0275" refid="t0010">Table 2</ce:cross-ref>
                        <ce:float-anchor refid="t0010"/>, none of the baseline miR values were associated with the primary endpoint, or the secondary endpoint comprising HF hospitalisations only.</ce:para>
                  </ce:section>
                  <ce:section id="s0060" view="all">
                     <ce:label>3.3</ce:label>
                     <ce:section-title id="st0085">Temporal miR patterns and the primary endpoint</ce:section-title>
                     <ce:para id="p0115" view="all">During follow-up, we collected 923 blood samples, of which 885 were drawn before the occurrence of the primary endpoint (median of 3 (IQR 2–5) samples per patient). MiRs were successfully determined in 873 of these samples. The temporal pattern of miR-22-3p was inversely associated with the primary endpoint (age and gender adjusted HR per doubling of miR-22-3p level, 0.64; CI 0.47–0.77; p<ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.001), i.e. higher miR-22-3p was associated with lower risk of events (<ce:cross-ref id="cf0280" refid="t0015">Table 3</ce:cross-ref>
                        <ce:float-anchor refid="t0015"/>). As described above, baseline measurements of several miRs were associated with ICM. On the other hand, NYHA class was independently associated with the primary endpoint. Therefore, the baseline variables ICM and NYHA class were added to the models. After adjustment for age, gender, NYHA class and ICM, the association between the temporal pattern of miR-22-3p and the primary endpoint remained present (HR per doubling of miR-22-3p level 0.71; CI 0.44–0.94; p<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0.005). When serial NYHA class assessments were added to the model instead of baseline NYHA assessments only, the association between miR miR-22-3p and the primary endpoint also remained present (HR per doubling of miR-22-3p level, 0.52; CI 0.44–0.61; p<ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.001). The temporal patterns of the other 6 miRs were not significantly associated with the primary endpoint.</ce:para>
                     <ce:para id="p0120" view="all">Baseline echocardiograms were available in 72% of all patients due to logistic reasons. After correction for left ventricular ejection fraction in this subgroup, miR-22-3p remained significantly associated with the primary endpoint (HR per doubling of miR-22-3p level, 0.91; CI 0.85–0.95; p<ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.001).</ce:para>
                     <ce:para id="p0125" view="all">
                        <ce:cross-ref id="cf0285" refid="f0015">Fig. 3</ce:cross-ref>
                        <ce:float-anchor refid="f0015"/> shows that in the patients who reached the endpoint, miR-22-3p values declined as this endpoint approached, while in the patients who did not reach the endpoint, miR-22-3p values remained stable.</ce:para>
                  </ce:section>
                  <ce:section id="s0065" view="all">
                     <ce:label>3.4</ce:label>
                     <ce:section-title id="st0090">Slope and area under the curve of the temporal miR patterns and the primary endpoint</ce:section-title>
                     <ce:para id="p0130" view="all">The hazard ratios for the doubling of the slopes and areas under the curve of the temporal miR patterns are displayed in <ce:cross-ref id="cf0290" refid="t0015">Table 3</ce:cross-ref>. For 4 of the miRs (miR-345-5p, miR-378a-3p, miR-423-5p, and miR-486-5p), slopes remained virtually constant over time, and hazard ratios were not calculable. The slope of the temporal pattern of miR-22-3p was inversely associated with the primary endpoint after multivariable adjustment (HR per doubling of miR-22-3p slope at any given time point, 0.33; CI 0.20–0.51; p<ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.001), while the slopes of the patterns of miR-1254 and miR-320a were not. None of the areas under the curves of the temporal miR patterns were associated with the primary endpoint.</ce:para>
                  </ce:section>
                  <ce:section id="s0070" view="all">
                     <ce:label>3.5</ce:label>
                     <ce:section-title id="st0095">Temporal patterns of miRs, NT-proBNP, Hs-TNT and CRP combined in a multiple-marker model</ce:section-title>
                     <ce:para id="p0135" view="all">After constructing the multivariable models that corrected for age, sex, ICM and NYHA class, we proceeded to additionally adjust the association between the temporal miR-22-3p pattern and the primary endpoint for temporal patterns of the other biomarkers which were measured in this study (NT-proBNP, HsTNT and CRP). We did this by entering the multivariably adjusted temporal pattern of miR-22-3p, as well as the multivariably adjusted temporal patterns of NT-proBNP, HsTNT and CRP simultaneously into one model. We found an independent association of miR-22-3p (HR per doubling of miR-22-3p level at any given time point, 0.61; CI 0.51–0.73; p<ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.001) with the primary endpoint. Temporal patterns of NT-proBNP and CRP level were also independently associated with the primary endpoint in the multiple-marker model (HRs: 1.34 (1.04–1.71) and 2.14 (1.59–2.88), respectively), while the temporal pattern of HsTNT was not (HR: 1.30 (0.91–1.84)). The slope of the temporal pattern of miR-22-3p also remained significantly associated with the primary endpoint after adjustment for the slopes of the temporal patterns of NT-proBNP, Troponin T and CRP (HR per doubling of miR-22-3p slope at any given time point, 0.55 (0.46–0.65); p<ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.001).</ce:para>
                  </ce:section>
                  <ce:section id="s0075" view="all">
                     <ce:label>3.6</ce:label>
                     <ce:section-title id="st0100">Repeated miR measurements and other biomarkers</ce:section-title>
                     <ce:para id="p0140" view="all">Associations between repeatedly measured miR and repeatedly measured NT-proBNP, HsTNT and CRP, calculated using generalised estimating equations, are displayed in <ce:cross-ref id="cf0295" refid="t0020">Table 4</ce:cross-ref>
                        <ce:float-anchor refid="t0020"/>. Of note are the significant inverse associations between miR-345-5p and CRP (β-coefficient [95% CI]: −<ce:hsp sp="0.10"/>0.04 [−<ce:hsp sp="0.10"/>0.07 to −<ce:hsp sp="0.10"/>0.01] 10log(mg/l) per 10log increase in miR-345-5p level; p<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0.012) and miR-22-3p and HsTNT (β-coefficient [95% CI]: −<ce:hsp sp="0.10"/>0.01 [−<ce:hsp sp="0.10"/>0.02 to −<ce:hsp sp="0.10"/>0.00] 10log(mg/l) per 10log increase in miR-22-3p level; p<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0.014; as well as the borderline significant inverse association between miR-22-3p and CRP (β-coefficient [95% CI]: −<ce:hsp sp="0.10"/>0.02 [−<ce:hsp sp="0.10"/>0.04–0.00] 10log (mg/l) per 10log increase in miR-22-3p level; p<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0.051). No further associations between repeatedly measured miR and repeatedly measured NT-proBNP, HsTNT and CRP were found.</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="s0080" view="all">
                  <ce:label>4</ce:label>
                  <ce:section-title id="st0105">Discussion</ce:section-title>
                  <ce:para id="p0145" view="all">In this prospective, observational cohort of CHF patients, temporal miR-22-3p patterns were inversely and independently associated with adverse outcome. The association was independent of temporal NT-proBNP, HsTNT and CRP patterns. The instant rate of change in miR-22-3p level (in terms of the slope of the temporal pattern) was also inversely associated with adverse outcome. Moreover, we found inverse associations of temporal patterns of miR-22-3p with temporal patterns of HsTNT and CRP. An additional finding of this study was the significant, inverse association between ICM and miR-1254, miR486-5p and miR-320a.</ce:para>
                  <ce:para id="p0150" view="all">Our study has several strengths. Although the number of incident endpoints was limited, this is the largest study to date that has examined miRs in a prospective cohort of patients with chronic HF. NT-proBNP, HsTNT and CRP were measured concomitantly, and, in addition, frequent repeated measurements were performed during follow-up, both of the miRs and of the established blood biomarkers. Statistical models containing all these, repeatedly measured, biomarkers were constructed and modern statistical methods were applied (‘joint modelling’), which take into account the continuous, dynamic changes in biomarker patterns and thus result in less bias than simpler analyses such as delta's between two measurements. Herewith, the study expands existing evidence with regard to miRs and cardiovascular disease in several respects.</ce:para>
                  <ce:para id="p0155" view="all">MiR-22-3p has previously received attention in the cancer field; it has been implicated in the regulation of various cellular processes, including cell growth, apoptosis, motility, and the cell cycle <ce:cross-ref id="cf0300" refid="bb0155">[31]</ce:cross-ref>. With regard to cardiovascular disease, fundamental experiments have demonstrated that expression of miR-22-3p is enriched in striated muscle tissues (i.e. cardiac and skeletal muscles); and miR-22-3p is thought to be required for normal cardiac remodelling in response to stresses <ce:cross-ref id="cf0305" refid="bb0160">[32]</ce:cross-ref>. A recent study in miR-22 deficient mice demonstrated that miR-22 depleted hearts quickly progress to adverse cardiac remodelling and develop cardiac dilation, with increased cardiomyocyte loss and deposition of fibrotic tissue, and signs of heart failure <ce:cross-ref id="cf0310" refid="bb0165">[33]</ce:cross-ref>. Another study also found that mice without miR-22 develop dilatation of myocardium more quickly <ce:cross-ref id="cf0315" refid="bb0170">[34]</ce:cross-ref>. Interestingly, several animal models have shown that miR-22 may potentially serve as a therapeutic target in cardiac hypertrophy <ce:cross-ref id="cf0320" refid="bb0165">[33]</ce:cross-ref>. Recently, Gupta et al found that pharmacological inhibition of miR-22 post-infarction activated cardiac autophagy, led to improved cardiac function, and inhibited cardiac remodelling in older mice <ce:cross-ref id="cf0325" refid="bb0175">[35]</ce:cross-ref>. They also found that circulating miR-22 provides prognostic information in HF patients. Specifically, they demonstrated an association between higher baseline levels of circulating miR-22 and mortality in154 HF patients. Repeated measurements were not performed. In the present study, although we saw a temporal decline of miR-22-3p levels in patients with adverse clinical outcome, we could not demonstrate a significant association between higher baseline miR-22-3p and clinical outcome. The shorter follow-up duration of our study (median of approx. 1<ce:hsp sp="0.25"/>year, versus 3<ce:hsp sp="0.25"/>years follow-up in the study of Gupta et al) may have contributed to this. Furthermore, in an earlier study, Goren et al, demonstrated that elevated serum levels of miR-22-3p identify patients with systolic heart failure using 30 stable chronic systolic heart failure patients and 30 controls <ce:cross-ref id="cf0330" refid="bb0120">[24]</ce:cross-ref>. This seeming discrepancy with our study could possibly be explained by differences in study design. While Goren et al focused on diagnostic properties of miR-22-3p by comparing cases and controls, we focused on prognostic value of miR-22-3p in patients with established CHF. To the best of our knowledge, other cardiovascular studies on miR-22-3p in human subjects are lacking. Altogether, our study is in line with previous fundamental experiments which demonstrated that loss of miR-22-3p leads to dilatation of myocardium and progressive HF. Our study confirms that lower levels of miR-22-3p are associated with worsening of CHF, and that miR-22-3p may complement established HF biomarkers in prognostication.</ce:para>
                  <ce:para id="p0160" view="all">Previously, several studies using animal models have shown decreased levels of miR-378a-3p during cardiac remodelling <ce:cross-ref id="cf0335" refid="bb0180">[36]</ce:cross-ref> and in HF due to cardiac hypertrophy <ce:cross-refs id="cf0340" refid="bb0185 bb0190 bb0195">[37–39]</ce:cross-refs>. Furthermore, a significant down-regulation of miR-378a-3p in hearts with dilated cardiomyopathy compared to non-failing control hearts has been observed <ce:cross-ref id="cf0345" refid="bb0115">[23]</ce:cross-ref>. Since the presence of miR-378a-3p is required to resist ventricular remodelling during cardiac stress, it may offer therapeutic potential for the management of HF <ce:cross-ref id="cf0350" refid="bb0190">[38]</ce:cross-ref>. It has been suggested, that up-regulation of miR-378a-3p could serve as a potential novel treatment for apoptosis and ischemic heart disease, since up-regulation of this miR enhanced cell viability, and inhibited apoptosis and necrosis in myocardium of rats <ce:cross-ref id="cf0355" refid="bb0200">[40]</ce:cross-ref>. In the current study, we also observed a tendency towards an inverse association between the temporal pattern of miR378a-3p and the primary endpoint in univariable models. These results concur with the aforementioned studies.</ce:para>
                  <ce:para id="p0165" view="all">Another miR that has previously been associated with HF, is miR-423-5p <ce:cross-refs id="cf0360" refid="bb0095 bb0105 bb0110 bb0120">[19,21,22,24]</ce:cross-refs>. However, in our study, there was no association between the temporal pattern of miR-423-5p and the primary endpoint. Existing studies on miR-423-5p in humans all compared single measurements in (C)HF patients with measurements in healthy controls, and imply that this miR has diagnostic value for HF <ce:cross-refs id="cf0365" refid="bb0095 bb0105 bb0120">[19,21,24]</ce:cross-refs>. We did not evaluate the diagnostic value of miRs, but the prognostic value of serial miR measurements in patients with known CHF. Although miR-423-5p may discriminate between HF patients and healthy controls, it may lack prognostic value in patients with longstanding CHF. Earlier findings support this hypothesis <ce:cross-ref id="cf0370" refid="bb0100">[20]</ce:cross-ref>. Bauters et al. serially measured serum levels of circulating miR-423-5p in 246 patients with a first anterior Q-wave myocardial infarction, at discharge and subsequently at 3<ce:hsp sp="0.25"/>months and 1<ce:hsp sp="0.25"/>year. They found no association between miR-423-5p levels and indices of left ventricular function and left ventricular remodelling, which were serially assessed during a 1<ce:hsp sp="0.25"/>year period after the index myocardial infarction, nor with B-type natriuretic peptide. They concluded that miR-423-5p is not a useful biomarker of left ventricular remodelling after myocardial infarction <ce:cross-ref id="cf0375" refid="bb0100">[20]</ce:cross-ref>.</ce:para>
                  <ce:para id="p0170" view="all">The selection of the miRs for the current investigation was based on previous studies, which used animal models and relatively small patient groups. Some of these studies have shown associations between miR-1254, miR-345-5p, miR-486-5p and miR-320a and heart failure <ce:cross-refs id="cf0380" refid="bb0095 bb0105 bb0120 bb0205 bb0210">[19,21,24,41,42]</ce:cross-refs>. Again, these were mostly studies that compared HF patients to healthy controls. In our study, we did not find any associations between these miRs and poor outcome in CHF. Multiple other miRs, such as miR-133a <ce:cross-ref id="cf0385" refid="bb0215">[43]</ce:cross-ref>, have previously been associated with HF <ce:cross-ref id="cf0390" refid="bb0220">[44]</ce:cross-ref>. Serial measurements of these other miRs, which were not investigated in this study, warrant further investigation. This could lead to further improvements in CHF prognostication, as well as tailored adjustment of treatment.</ce:para>
                  <ce:para id="p0175" view="all">Some aspects of this study warrant consideration. For the current investigation we only used the first round of inclusions of the ongoing Bio-SHiFT study (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>263). It should be noted that the full Bio-SHiFT cohort is designed to have sufficient statistical power to enable correction for multiple testing in case of application of modern, large-scale biomarker measurement methods. However, the current investigation examines only 7 miRs, which were chosen based on pathophysiological considerations. Thus, the current investigation was hypothesis-driven and not data-driven, rendering correction for multiple testing unnecessary in this particular case. Furthermore, with an average follow-up ~<ce:hsp sp="0.10"/>1<ce:hsp sp="0.25"/>year, the number of primary endpoints in the current investigation (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>41) was limited, and consequently so was the number of covariables that could be entered into the models. The lack of a replication population is another limitation of the study. Finally, the majority of the patient population was in NYHA functional class I or II, and thus at relatively low risk. Accordingly, the primary outcome was predominantly composed of heart failure hospitalizations. This may have hampered the prognostic information of the other miRs tested in this study. Future studies using high-risk patient populations should therefore re-investigate the prognostic information carried by repeated assessment of these miRs.</ce:para>
                  <ce:para id="p0180" view="all">Remarkably, in the present study, the rate of HFPEF was very low compared to other epidemiological studies. This can most likely be attributed to the fact that in the Netherlands, most HFPEF patients are treated by the general practitioner or in secondary referral centres, while the current study was performed in two centres which were both tertiary referral centres. Potential inclusion bias is not a likely reason for the low HPEF rate, because consecutive patients were screened in both participating centres. Moreover, the number of patients on vitamin K antagonists was quite high in this study, most likely due to the high number of patients with left ventricular aneurysms and thrombi, as well as the high number of patients with atrial fibrillation.</ce:para>
                  <ce:para id="p0185" view="all">In conclusion, in patients with stable CHF, the temporal pattern of circulating miR-22-3p is a strong and independent predictor of prognosis. Thus, the use of individual patterns of change of circulating miR-22-3p for CHF prognostication, as well as for tailored adjustment of treatment, warrants further investigation.</ce:para>
                  <ce:para view="extended" id="p0190">The following are the supplementary data related to this article.<ce:display>
                        <ce:e-component id="ec0005">
                           <ce:label>Supplemental table</ce:label>
                           <ce:caption id="ca0040">
                              <ce:simple-para id="sp0090" view="all">Associations between baseline characteristics and miRNAs measured at baseline.</ce:simple-para>
                           </ce:caption>
                           <ce:alt-text role="short" id="al0040">Supplemental table</ce:alt-text>
                           <ce:link id="lk0020" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/46.1" locator="mmc1" xlink:type="simple" xlink:href="pii:S0167527317311075/mmc1"/>
                        </ce:e-component>
                     </ce:display>
                  </ce:para>
                  <ce:para view="compact-standard" id="p0195">Supplementary data to this article can be found online at <ce:inter-ref xlink:href="http://dx.doi.org/10.1016/j.ijcard.2017.02.078" id="ir0005" xlink:type="simple">http://dx.doi.org/10.1016/j.ijcard.2017.02.078</ce:inter-ref>.</ce:para>
               </ce:section>
               <ce:section id="s0085" view="all">
                  <ce:section-title id="st0110">Funding sources</ce:section-title>
                  <ce:para id="p0200" view="all">This work was supported by the <ce:grant-sponsor id="gts0005" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Jaap Schouten Foundation</ce:grant-sponsor> and the <ce:grant-sponsor id="gts0010" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Foreest Medical School</ce:grant-sponsor>.</ce:para>
               </ce:section>
               <ce:section id="s0090" view="all">
                  <ce:section-title id="st0115">Conflicts of interest</ce:section-title>
                  <ce:para id="p0205" view="all">MiR measurements were performed by ACS Biomarker BV. ACS Biomarker had no role in the study design, analysis and interpretation of data, writing of the manuscript, or in the decision to submit the manuscript for publication. Dr. Y. Pinto has a commercial interest in ACS Biomarker (&lt;<ce:hsp sp="0.10"/>5%).</ce:para>
               </ce:section>
            </ce:sections>
            <ce:acknowledgment id="ac0005" view="all">
               <ce:section-title id="st0120">Acknowledgements</ce:section-title>
               <ce:para id="p0210" view="all">We would like to thank the following staff for their contribution to this study: Lara Emilsdottir, Ymkje Hendriksma, Chris Jansen, Ellen Klaassen, Agnes Muskens, and Wout de Ruiter.</ce:para>
            </ce:acknowledgment>
         </body>
         <tail view="all">
            <ce:bibliography id="bi0005" view="all">
               <ce:section-title id="st0125">References</ce:section-title>
               <ce:bibliography-sec id="bs0005" view="all">
                  <ce:bib-reference id="bb0005">
                     <ce:label>[1]</ce:label>
                     <sb:reference id="rf0005">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Ponikowski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.A.</ce:given-name>
                                 <ce:surname>Voors</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.D.</ce:given-name>
                                 <ce:surname>Anker</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Bueno</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.G.</ce:given-name>
                                 <ce:surname>Cleland</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.J.</ce:given-name>
                                 <ce:surname>Coats</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Falk</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.R.</ce:given-name>
                                 <ce:surname>Gonzalez-Juanatey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.P.</ce:given-name>
                                 <ce:surname>Harjola</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.A.</ce:given-name>
                                 <ce:surname>Jankowska</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Jessup</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Linde</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Nihoyannopoulos</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.T.</ce:given-name>
                                 <ce:surname>Parissis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Pieske</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.P.</ce:given-name>
                                 <ce:surname>Riley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.M.</ce:given-name>
                                 <ce:surname>Rosano</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.M.</ce:given-name>
                                 <ce:surname>Ruilope</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Ruschitzka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.H.</ce:given-name>
                                 <ce:surname>Rutten</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>van der</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Heart Fail.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>8</sb:issue-nr>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>891</sb:first-page>
                              <sb:last-page>975</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0010">
                     <ce:label>[2]</ce:label>
                     <sb:reference id="rf0010">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.W.</ce:given-name>
                                 <ce:surname>Yancy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Jessup</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Bozkurt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Butler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.E.</ce:given-name>
                                 <ce:surname>Casey</ce:surname>
                                 <ce:suffix>Jr.</ce:suffix>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.H.</ce:given-name>
                                 <ce:surname>Drazner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.C.</ce:given-name>
                                 <ce:surname>Fonarow</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.A.</ce:given-name>
                                 <ce:surname>Geraci</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Horwich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Januzzi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.R.</ce:given-name>
                                 <ce:surname>Johnson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.K.</ce:given-name>
                                 <ce:surname>Kasper</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.C.</ce:given-name>
                                 <ce:surname>Levy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.A.</ce:given-name>
                                 <ce:surname>Masoudi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.E.</ce:given-name>
                                 <ce:surname>McBride</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>McMurray</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Mitchell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.N.</ce:given-name>
                                 <ce:surname>Peterson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Riegel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Sam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.W.</ce:given-name>
                                 <ce:surname>Stevenson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.H.</ce:given-name>
                                 <ce:surname>Tang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.J.</ce:given-name>
                                 <ce:surname>Tsai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.L.</ce:given-name>
                                 <ce:surname>Wilkoff</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Am. Coll. Cardiol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>62</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>16</sb:issue-nr>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>e147</sb:first-page>
                              <sb:last-page>e239</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0015">
                     <ce:label>[3]</ce:label>
                     <sb:reference id="rf0015">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Januzzi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Troughton</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Circulation</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>127</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>4</sb:issue-nr>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>500</sb:first-page>
                              <sb:last-page>507</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0020">
                     <ce:label>[4]</ce:label>
                     <sb:reference id="rf0020">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>de Couto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ouzounian</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.P.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Early detection of myocardial dysfunction and heart failure</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Rev. Cardiol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>7</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>6</sb:issue-nr>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>334</sb:first-page>
                              <sb:last-page>344</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0025">
                     <ce:label>[5]</ce:label>
                     <sb:reference id="rf0025">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Savarese</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Trimarco</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Dellegrottaglie</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Prastaro</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Gambardella</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Rengo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Leosco</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Perrone-Filardi</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>PLoS One</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>8</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>3</sb:issue-nr>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:article-number>e58287</sb:article-number>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0030">
                     <ce:label>[6]</ce:label>
                     <sb:reference id="rf0030">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Porapakkham</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Porapakkham</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Zimmet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Billah</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Krum</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>B-type natriuretic peptide-guided heart failure therapy: a meta-analysis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Arch. Intern. Med.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>170</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>6</sb:issue-nr>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>507</sb:first-page>
                              <sb:last-page>514</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0035">
                     <ce:label>[7]</ce:label>
                     <sb:reference id="rf0035">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>W.L.</ce:given-name>
                                 <ce:surname>Miller</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.A.</ce:given-name>
                                 <ce:surname>Hartman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.F.</ce:given-name>
                                 <ce:surname>Burritt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.E.</ce:given-name>
                                 <ce:surname>Grill</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.J.</ce:given-name>
                                 <ce:surname>Rodeheffer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.C.</ce:given-name>
                                 <ce:surname>Burnett</ce:surname>
                                 <ce:suffix>Jr.</ce:suffix>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.S.</ce:given-name>
                                 <ce:surname>Jaffe</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Circulation</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>116</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>3</sb:issue-nr>
                              <sb:date>2007</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>249</sb:first-page>
                              <sb:last-page>257</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0040">
                     <ce:label>[8]</ce:label>
                     <sb:reference id="rf0040">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.T.</ce:given-name>
                                 <ce:surname>Yan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>White</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.T.</ce:given-name>
                                 <ce:surname>Yan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Yusuf</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Rouleau</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.P.</ce:given-name>
                                 <ce:surname>Maggioni</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Hall</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Latini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Afzal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Floras</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Masson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.S.</ce:given-name>
                                 <ce:surname>McKelvie</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Am. J. Cardiol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>96</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>5</sb:issue-nr>
                              <sb:date>2005</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>698</sb:first-page>
                              <sb:last-page>704</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0045">
                     <ce:label>[9]</ce:label>
                     <sb:reference id="rf0045">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Troughton</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.G.</ce:given-name>
                                 <ce:surname>Michael</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Januzzi</ce:surname>
                                 <ce:suffix>Jr.</ce:suffix>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Natriuretic peptide-guided heart failure management</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. Heart J.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>35</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>1</sb:issue-nr>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>16</sb:first-page>
                              <sb:last-page>24</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0050">
                     <ce:label>[10]</ce:label>
                     <sb:reference id="rf0050">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.P.</ce:given-name>
                                 <ce:surname>Bartel</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>MicroRNAs: genomics, biogenesis, mechanism, and function</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cell</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>116</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>2</sb:issue-nr>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>281</sb:first-page>
                              <sb:last-page>297</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0055">
                     <ce:label>[11]</ce:label>
                     <sb:reference id="rf0055">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Gilad</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Meiri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Yogev</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Benjamin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Lebanony</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Yerushalmi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Benjamin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kushnir</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Cholakh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Melamed</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Bentwich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Hod</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Goren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Chajut</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Serum microRNAs are promising novel biomarkers</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>PLoS One</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>3</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>9</sb:issue-nr>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:article-number>e3148</sb:article-number>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0060">
                     <ce:label>[12]</ce:label>
                     <sb:reference id="rf0060">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.F.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.P.</ce:given-name>
                                 <ce:surname>Murchison</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Tang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.E.</ce:given-name>
                                 <ce:surname>Callis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Tatsuguchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Deng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Rojas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.M.</ce:given-name>
                                 <ce:surname>Hammond</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.D.</ce:given-name>
                                 <ce:surname>Schneider</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.H.</ce:given-name>
                                 <ce:surname>Selzman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Meissner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Patterson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.J.</ce:given-name>
                                 <ce:surname>Hannon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.Z.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>105</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>6</sb:issue-nr>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2111</sb:first-page>
                              <sb:last-page>2116</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0065">
                     <ce:label>[13]</ce:label>
                     <sb:reference id="rf0065">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.A.</ce:given-name>
                                 <ce:surname>Costa Martins</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Bourajjaj</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Gladka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kortland</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.J.</ce:given-name>
                                 <ce:surname>van Oort</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.M.</ce:given-name>
                                 <ce:surname>Pinto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.D.</ce:given-name>
                                 <ce:surname>Molkentin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.J.</ce:given-name>
                                 <ce:surname>De Windt</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Circulation</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>118</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>15</sb:issue-nr>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1567</sb:first-page>
                              <sb:last-page>1576</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0070">
                     <ce:label>[14]</ce:label>
                     <sb:reference id="rf0070">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>E.E.</ce:given-name>
                                 <ce:surname>Creemers</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.J.</ce:given-name>
                                 <ce:surname>Tijsen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.M.</ce:given-name>
                                 <ce:surname>Pinto</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Circ. Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>110</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>3</sb:issue-nr>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>483</sb:first-page>
                              <sb:last-page>495</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0075">
                     <ce:label>[15]</ce:label>
                     <sb:reference id="rf0075">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Vogel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Keller</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.S.</ce:given-name>
                                 <ce:surname>Frese</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Kloos</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Kayvanpour</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Sedaghat-Hamedani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Hassel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Marquart</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Beier</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Giannitis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Hardt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.A.</ce:given-name>
                                 <ce:surname>Katus</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Meder</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Refining diagnostic microRNA signatures by whole-miRNome kinetic analysis in acute myocardial infarction</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Clin. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>59</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>2</sb:issue-nr>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>410</sb:first-page>
                              <sb:last-page>418</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0080">
                     <ce:label>[16]</ce:label>
                     <sb:reference id="rf0080">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Zampetaki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Willeit</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Tilling</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Drozdov</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Prokopi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Renard</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Mayr</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Weger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Schett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Shah</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.M.</ce:given-name>
                                 <ce:surname>Boulanger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Willeit</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.J.</ce:given-name>
                                 <ce:surname>Chowienczyk</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Kiechl</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Mayr</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Prospective study on circulating MicroRNAs and risk of myocardial infarction</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Am. Coll. Cardiol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>60</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>4</sb:issue-nr>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>290</sb:first-page>
                              <sb:last-page>299</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0085">
                     <ce:label>[17]</ce:label>
                     <sb:reference id="rf0085">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.F.</ce:given-name>
                                 <ce:surname>Corsten</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Dennert</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Jochems</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Kuznetsova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Devaux</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Hofstra</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.R.</ce:given-name>
                                 <ce:surname>Wagner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Staessen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Heymans</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Schroen</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Circ. Cardiovasc. Genet.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>3</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>6</sb:issue-nr>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>499</sb:first-page>
                              <sb:last-page>506</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0090">
                     <ce:label>[18]</ce:label>
                     <sb:reference id="rf0090">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Olivieri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Antonicelli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Lorenzi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>D'Alessandra</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Lazzarini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Santini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Spazzafumo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Lisa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>La Sala</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Galeazzi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Recchioni</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Testa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Pompilio</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.C.</ce:given-name>
                                 <ce:surname>Capogrossi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.D.</ce:given-name>
                                 <ce:surname>Procopio</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Int. J. Cardiol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>167</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>2</sb:issue-nr>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>531</sb:first-page>
                              <sb:last-page>536</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0095">
                     <ce:label>[19]</ce:label>
                     <sb:reference id="rf0095">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.A.</ce:given-name>
                                 <ce:surname>Goldraich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.C.</ce:given-name>
                                 <ce:surname>Martinelli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>U.</ce:given-name>
                                 <ce:surname>Matte</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Cohen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Andrades</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Pimentel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Biolo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Clausell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.E.</ce:given-name>
                                 <ce:surname>Rohde</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Transcoronary gradient of plasma microRNA 423-5p in heart failure: evidence of altered myocardial expression</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Biomarkers</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>19</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>2</sb:issue-nr>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>135</sb:first-page>
                              <sb:last-page>141</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0100">
                     <ce:label>[20]</ce:label>
                     <sb:reference id="rf0100">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Bauters</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Kumarswamy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Holzmann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Bretthauer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.D.</ce:given-name>
                                 <ce:surname>Anker</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Pinet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Thum</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Int. J. Cardiol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>168</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>3</sb:issue-nr>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1837</sb:first-page>
                              <sb:last-page>1840</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0105">
                     <ce:label>[21]</ce:label>
                     <sb:reference id="rf0105">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.J.</ce:given-name>
                                 <ce:surname>Tijsen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.E.</ce:given-name>
                                 <ce:surname>Creemers</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.D.</ce:given-name>
                                 <ce:surname>Moerland</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.J.</ce:given-name>
                                 <ce:surname>De Windt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.C.</ce:given-name>
                                 <ce:surname>van der Wal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.E.</ce:given-name>
                                 <ce:surname>Kok</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.M.</ce:given-name>
                                 <ce:surname>Pinto</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>MiR423-5p as a circulating biomarker for heart failure</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Circ. Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>106</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>6</sb:issue-nr>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1035</sb:first-page>
                              <sb:last-page>1039</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0110">
                     <ce:label>[22]</ce:label>
                     <sb:reference id="rf0110">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.A.</ce:given-name>
                                 <ce:surname>Dickinson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.M.</ce:given-name>
                                 <ce:surname>Semus</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.L.</ce:given-name>
                                 <ce:surname>Montgomery</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Stack</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.A.</ce:given-name>
                                 <ce:surname>Latimer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.M.</ce:given-name>
                                 <ce:surname>Lewton</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Lynch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.G.</ce:given-name>
                                 <ce:surname>Hullinger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.G.</ce:given-name>
                                 <ce:surname>Seto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>van Rooij</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Heart Fail.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>15</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>6</sb:issue-nr>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>650</sb:first-page>
                              <sb:last-page>659</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0115">
                     <ce:label>[23]</ce:label>
                     <sb:reference id="rf0115">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.V.</ce:given-name>
                                 <ce:surname>Naga Prasad</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.H.</ce:given-name>
                                 <ce:surname>Duan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.K.</ce:given-name>
                                 <ce:surname>Gupta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.S.</ce:given-name>
                                 <ce:surname>Surampudi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Volinia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.A.</ce:given-name>
                                 <ce:surname>Calin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.G.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Kotwal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.S.</ce:given-name>
                                 <ce:surname>Moravec</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.C.</ce:given-name>
                                 <ce:surname>Starling</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.M.</ce:given-name>
                                 <ce:surname>Perez</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Sen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.F.</ce:given-name>
                                 <ce:surname>Plow</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.M.</ce:given-name>
                                 <ce:surname>Croce</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Karnik</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>284</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>40</sb:issue-nr>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>27487</sb:first-page>
                              <sb:last-page>27499</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0120">
                     <ce:label>[24]</ce:label>
                     <sb:reference id="rf0120">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Goren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kushnir</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Zafrir</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Tabak</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.S.</ce:given-name>
                                 <ce:surname>Lewis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.</ce:given-name>
                                 <ce:surname>Amir</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Serum levels of microRNAs in patients with heart failure</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Heart Fail.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>14</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>2</sb:issue-nr>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>147</sb:first-page>
                              <sb:last-page>154</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0125">
                     <ce:label>[25]</ce:label>
                     <sb:reference id="rf0125">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>McMurray</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Adamopoulos</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.D.</ce:given-name>
                                 <ce:surname>Anker</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Auricchio</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Bohm</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Dickstein</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Falk</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Filippatos</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Fonseca</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Gomez-Sanchez</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Jaarsma</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Kober</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.Y.</ce:given-name>
                                 <ce:surname>Lip</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.P.</ce:given-name>
                                 <ce:surname>Maggioni</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Parkhomenko</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.M.</ce:given-name>
                                 <ce:surname>Pieske</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.A.</ce:given-name>
                                 <ce:surname>Popescu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.K.</ce:given-name>
                                 <ce:surname>Ronnevik</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.H.</ce:given-name>
                                 <ce:surname>Rutten</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Schwitter</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Seferovic</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Stepinska</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Trindade</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.A.</ce:given-name>
                                 <ce:surname>Voors</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Zannad</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Zeiher</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. Heart J.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>
                                    <ce:bold>33</ce:bold>
                                 </sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>14</sb:issue-nr>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1787</sb:first-page>
                              <sb:last-page>1847</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0130">
                     <ce:label>[26]</ce:label>
                     <sb:reference id="rf0130">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Dickstein</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Cohen-Solal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Filippatos</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>McMurray</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Ponikowski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.A.</ce:given-name>
                                 <ce:surname>Poole-Wilson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Stromberg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.J.</ce:given-name>
                                 <ce:surname>van Veldhuisen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Atar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.W.</ce:given-name>
                                 <ce:surname>Hoes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Keren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Mebazaa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Nieminen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.G.</ce:given-name>
                                 <ce:surname>Priori</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Swedberg</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. Heart J.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>29</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>19</sb:issue-nr>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2388</sb:first-page>
                              <sb:last-page>2442</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0135">
                     <ce:label>[27]</ce:label>
                     <sb:reference id="rf0135">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>W.J.</ce:given-name>
                                 <ce:surname>Paulus</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Tschope</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Sanderson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Rusconi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.A.</ce:given-name>
                                 <ce:surname>Flachskampf</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.E.</ce:given-name>
                                 <ce:surname>Rademakers</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Marino</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.A.</ce:given-name>
                                 <ce:surname>Smiseth</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>De Keulenaer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.F.</ce:given-name>
                                 <ce:surname>Leite-Moreira</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Borbely</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Edes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.L.</ce:given-name>
                                 <ce:surname>Handoko</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Heymans</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Pezzali</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Pieske</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Dickstein</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.G.</ce:given-name>
                                 <ce:surname>Fraser</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.L.</ce:given-name>
                                 <ce:surname>Brutsaert</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. Heart J.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>28</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>20</sb:issue-nr>
                              <sb:date>2007</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2539</sb:first-page>
                              <sb:last-page>2550</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0140">
                     <ce:label>[28]</ce:label>
                     <sb:reference id="rf0140">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.K.</ce:given-name>
                                 <ce:surname>Rao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Toyama</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.R.</ce:given-name>
                                 <ce:surname>Chiang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Gupta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Bauer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Medvid</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Reinhardt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Liao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Krieger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Jaenisch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.F.</ce:given-name>
                                 <ce:surname>Lodish</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Blelloch</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Circ. Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>105</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>6</sb:issue-nr>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>585</sb:first-page>
                              <sb:last-page>594</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0145">
                     <ce:label>[29]</ce:label>
                     <sb:reference id="rf0145">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Rizopoulos</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>JM: an R package for the joint modelling of longitudinal and time-to-event data</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Stat. Softw.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>35</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>9</sb:issue-nr>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1</sb:first-page>
                              <sb:last-page>33</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0150">
                     <ce:label>[30]</ce:label>
                     <sb:reference id="rf0150">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Rizopoulos</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Joint Models for Longitudinal and Time-to-Event Data: With Applications in R</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2012</sb:date>
                              <sb:publisher>
                                 <sb:name>Chapman &amp; Hall/CRC</sb:name>
                                 <sb:location>Boca Raton</sb:location>
                              </sb:publisher>
                           </sb:book>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0155">
                     <ce:label>[31]</ce:label>
                     <sb:reference id="rf0155">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Liang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Ma</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Lu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Gynecol. Oncol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>119</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>3</sb:issue-nr>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>543</sb:first-page>
                              <sb:last-page>548</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0160">
                     <ce:label>[32]</ce:label>
                     <sb:reference id="rf0160">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Z.P.</ce:given-name>
                                 <ce:surname>Huang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.Z.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>miR-22 in cardiac remodeling and disease</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Trends Cardiovasc. Med.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>24</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>7</sb:issue-nr>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>267</sb:first-page>
                              <sb:last-page>272</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0165">
                     <ce:label>[33]</ce:label>
                     <sb:reference id="rf0165">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Z.P.</ce:given-name>
                                 <ce:surname>Huang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.Y.</ce:given-name>
                                 <ce:surname>Seok</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kataoka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Hu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.Z.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Circ. Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>112</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>9</sb:issue-nr>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1234</sb:first-page>
                              <sb:last-page>1243</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0170">
                     <ce:label>[34]</ce:label>
                     <sb:reference id="rf0170">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Gurha</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Abreu-Goodger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.O.</ce:given-name>
                                 <ce:surname>Ramirez</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.L.</ce:given-name>
                                 <ce:surname>Drumond</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.S.</ce:given-name>
                                 <ce:surname>van</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Bartonicek</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.J.</ce:given-name>
                                 <ce:surname>Enright</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.J.</ce:given-name>
                                 <ce:surname>Kelm</ce:surname>
                                 <ce:suffix>Jr.</ce:suffix>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.K.</ce:given-name>
                                 <ce:surname>Reddy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.E.</ce:given-name>
                                 <ce:surname>Taffet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Bradley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.H.</ce:given-name>
                                 <ce:surname>Wehrens</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.L.</ce:given-name>
                                 <ce:surname>Entman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Rodriguez</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Circulation</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>125</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>22</sb:issue-nr>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2751</sb:first-page>
                              <sb:last-page>2761</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0175">
                     <ce:label>[35]</ce:label>
                     <sb:reference id="rf0175">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.K.</ce:given-name>
                                 <ce:surname>Gupta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Foinquinos</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Thum</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Remke</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Zimmer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Bauters</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>de Groote</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.A.</ce:given-name>
                                 <ce:surname>Boon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.J.</ce:given-name>
                                 <ce:surname>De Windt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Preissl</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Hein</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Batkai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Pinet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Thum</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Preclinical development of a microRNA-based therapy for elderly patients with myocardial infarction</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Am. Coll. Cardiol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>68</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>14</sb:issue-nr>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1557</sb:first-page>
                              <sb:last-page>1571</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0180">
                     <ce:label>[36]</ce:label>
                     <sb:reference id="rf0180">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Knezevic</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Patel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.R.</ce:given-name>
                                 <ce:surname>Sundaresan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>Gupta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.J.</ce:given-name>
                                 <ce:surname>Solaro</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.S.</ce:given-name>
                                 <ce:surname>Nagalingam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Gupta</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>287</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>16</sb:issue-nr>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>12913</sb:first-page>
                              <sb:last-page>12926</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0185">
                     <ce:label>[37]</ce:label>
                     <sb:reference id="rf0185">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.S.</ce:given-name>
                                 <ce:surname>Nagalingam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.R.</ce:given-name>
                                 <ce:surname>Sundaresan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>Gupta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.L.</ce:given-name>
                                 <ce:surname>Geenen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.J.</ce:given-name>
                                 <ce:surname>Solaro</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Gupta</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>288</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>16</sb:issue-nr>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>11216</sb:first-page>
                              <sb:last-page>11232</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0190">
                     <ce:label>[38]</ce:label>
                     <sb:reference id="rf0190">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.S.</ce:given-name>
                                 <ce:surname>Nagalingam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.R.</ce:given-name>
                                 <ce:surname>Sundaresan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Noor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>Gupta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.J.</ce:given-name>
                                 <ce:surname>Solaro</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Gupta</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Deficiency of cardiomyocyte-specific MicroRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor beta (TGFbeta1)-dependent paracrine mechanism</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>289</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>39</sb:issue-nr>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>27199</sb:first-page>
                              <sb:last-page>27214</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0195">
                     <ce:label>[39]</ce:label>
                     <sb:reference id="rf0195">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Ganesan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Ramanujam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Sassi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Ahles</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Jentzsch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Werfel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Leierseder</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Loyer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Giacca</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Zentilin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Thum</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Laggerbauer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Engelhardt</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Circulation</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>127</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>21</sb:issue-nr>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2097</sb:first-page>
                              <sb:last-page>2106</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0200">
                     <ce:label>[40]</ce:label>
                     <sb:reference id="rf0200">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Fang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.W.</ce:given-name>
                                 <ce:surname>Song</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Tian</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.Y.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.F.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.F.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.J.</ce:given-name>
                                 <ce:surname>Ren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.J.</ce:given-name>
                                 <ce:surname>Yuan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Apoptosis</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>17</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>4</sb:issue-nr>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>410</sb:first-page>
                              <sb:last-page>423</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0205">
                     <ce:label>[41]</ce:label>
                     <sb:reference id="rf0205">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Sun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Jin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Geng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Ma</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Regulation by bisoprolol for cardiac microRNA expression in a rat volume-overload heart failure model</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Nanosci. Nanotechnol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>13</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>8</sb:issue-nr>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5267</sb:first-page>
                              <sb:last-page>5275</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0210">
                     <ce:label>[42]</ce:label>
                     <sb:reference id="rf0210">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>E.M.</ce:given-name>
                                 <ce:surname>Small</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.R.</ce:given-name>
                                 <ce:surname>O'Rourke</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Moresi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.B.</ce:given-name>
                                 <ce:surname>Sutherland</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>McAnally</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.D.</ce:given-name>
                                 <ce:surname>Gerard</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Richardson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.N.</ce:given-name>
                                 <ce:surname>Olson</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>107</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>9</sb:issue-nr>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4218</sb:first-page>
                              <sb:last-page>4223</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0215">
                     <ce:label>[43]</ce:label>
                     <sb:reference id="rf0215">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Besler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Urban</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Watzka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Lang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.P.</ce:given-name>
                                 <ce:surname>Rommel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Kandolf</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Klingel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Thiele</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Linke</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Schuler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Adams</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Lurz</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Heart Fail.</sb:maintitle>
                                 </sb:title>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0220">
                     <ce:label>[44]</ce:label>
                     <sb:reference id="rf0220">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>E.L.</ce:given-name>
                                 <ce:surname>Vegter</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>van der</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.J.</ce:given-name>
                                 <ce:surname>De Windt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.M.</ce:given-name>
                                 <ce:surname>Pinto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.A.</ce:given-name>
                                 <ce:surname>Voors</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>MicroRNAs in heart failure: from biomarker to target for therapy</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Heart Fail.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>5</sb:issue-nr>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>457</sb:first-page>
                              <sb:last-page>468</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
               </ce:bibliography-sec>
            </ce:bibliography>
         </tail>
      </article>
   </xocs:serial-item>
        </xocs:doc>
    </originalText>
</full-text-retrieval-response>